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Voorwoord 
In dit proefschrift worden twee onderzoeken beschreven naar de invloed van 
de soort en de hoeveelheid vet in de voeding op enkele risiko-indicatoren voor 
hart- en vaatziekten bij gezonde vrijwinigers. De resultaten zijn weergegeven 
in de vorm van vijf artikelen (hoofdstuk 2 t/m 6). In een bijlage is geprobeerd 
om niet-vakgenoten enig inzicht te geven in het verband tussen voeding en 
hart- en vaatziekten. 
Het onderzoek werd uitgevoerd op de vakgroep Humane Voeding van de Landbouw-
hogeschool, met financiele steun van de Nederlandse Hartstichting. 
Bij het onderzoek zijn veel mensen betrokken geweest, die hier niet onver-
meld mogen blijven. 
In de eerste plaats dank aan mijn promotor, prof.dr. J.G.A.J. Hautvast, 
voor zijn levendige belangstelling in alle fasen van het onderzoek. 
Martijn Katan heeft op bijzondere wijze aan het geheel bijgedragen. Het 
vrijwel dagelijkse contact met hem was erg prettig en altijd stimulerend. 
Prof.dr.ir. R.J.J. Hermus dank ik voor zijn adviezen bij de voorbereiding 
van het project. 
De dietistes Joke van Jeveren, Marita Engelen, Jeanne de Vries en Nettie 
van Kaathoven waren van onschatbare waarde. De verantwoordelijkheid voor de 
dagelijkse gang van zaken in de keuken tijdens de voorbereiding en uitvoering 
van de proeven rustte geheel op nun schouders. 
Zonder de opgewekte, enthousiaste en serieuze inzet van alle proefpersonen 
zou er van dit onderzoek niets terecht zijn gekomen; heel veel dank! 
Ook Annelies Geenen, Gerrie Duifhuyzen, de medewerkers van de Akademie 
Diedenoord, ir. P. Sluimer van het Instituut voor Graan, Meel en Brood te 
Wageningen, bakkerij Bouwman en de medewerkers van het Biotechnion dank ik 
voor hun bijdrage aan het soepele verloop van de proeven. 
De doktoraalstudenten Lisette Gruisen en Bas van Woelderen hebben een niet 
geringe bijdrage geleverd. Aan de samenwerking met hen bewaar ik prettige 
herinneringen. 
De vele gesprekken met mijn collega's Marianne Stasse-Wolthuis en Joop van 
Raay lijken mij onmisbaar te zijn geweest. Ook in praktische zaken waren zij 
steeds een grote steun. Clive West dank ik voor zijn hulp bij de voorbereiding 
van de manuscripten. 
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STELLINGEN 
1. In de Nederlandse situatie is zowel een drastische beperking van de 
hoeveelheid vet in de voeding als een matige vetbeperking gepaard gaande 
met verhoging van de 1inolzuurconsumptie effectief in net verlagen van 
het serum cholesterolgehalte. Drastische vetbeperking leidt echter tot 
lagere HDL-cholesterol- en hogere nuchtere serum triglyceridengehaltes. 
Dit proefschrift. 
Antonis, A. and Bersohn, I. The influence of diet on serum 
triglycerides in South African White and Bantu prisoners. 
Lancet i: 3, 1961. 
2. Het HDL-cholesterolgehalte wordt meer bepaald door de to ta le hoeveelheid 
vet dan door het aandeel van meervoudig onverzadigde vetzuren in de 
voeding. 
Dit proefschrift. 
3. Bij het uitbrengen van voedingsadviezen dient tegelijkertijd inzicht 
gegeven te worden in de mate van bescherming tegen ziekte die het opvolgen 
van die adviezen oplevert. 
4. Linolzuurrijke produkten zijn bij uitstek geschikt voor een serum 
cholesterol verlagend dieet; het aanprijzen van dergelijke produkten ter 
verlaging van de bloeddruk is echter voorbarig. 
Dit proefschrift. 
5. Bij de interpretatie van de resultaten van experimenten, waarin gebruik 
gemaakt is van vloeibare voedingen, wordt vaak onvoldoende rekening 
gehouden met het effect van dergelijke voedingen op de darmfysiologie. 
6. De toename in lichaamsgewicht die vaak optreedt wanneer men stopt met net 
roken van sigaretten vormt een beduidend kleiner risico voor de gezondheid 
dan het roken zelf. 
Sorlie, P., Gordon, T. and Kannel, W.B. Body build and mortality. The 
Framingham Study. J. Am. Med. Ass. 243: 1828, 1980. 
7. Het instellen van wijkraden van overheidswege is in de huidige praktijk 
strijdig met het beoogde doel: burgers meer directe invloed op de plaatse-
lijke bestuurlijke beslissingen te geven. 
8. Verhoging van de militaire investeringen leidt tot verlies van arbeids-
plaatsen. 
9. Bij de inrichting van werkruimten wordt er onvoldoende van uitgegaan dat 
het werk in deeltijd verricht moet kunnen worden. 
10. Voeding is geen wetenschap. 
Proefschrift J.H. Brussaard. 
A comparison of various cholesterol lowering diets in young healthy volunteers; 
effects on serum lipoproteins and on other risk indicators for cardiovascular 
diseases. 
Wageningen, 4 december 1981. 
Voor de chemische analyses ben ik veel dank schuldig aan Joke Barendse, 
Janny Bos, Peter van de Bovenkamp, Cock Germing-Nouwen, Elly Koot, Bea Nijhof, 
Frans Schouten, Ans Soffers en Henny Verwey. 
Hannie van Oosten-van der Goes dank ik voor haar hulp bij het computerwerk. 
Voor statistische adviezen dank ik dr.ir. M.A.J, van Montfort van de vakgroep 
Wiskunde en drs. Jan Burema. 
Velen buiten Wageningen boden hulp waar onze eigen analytische capaciteiten 
tekort schoten: prof.dr. Th.J. Benraad, prof.dr. A.P. Jansen, prof.dr. A. van 't 
Laar en hun medewerkers van het St.Radboudziekenhuis te Nijmegen; dr. M.A. 
Eastwood en W.G. Brydon van de Universiteit van Edinburgh; dr. P.H.E. Groot en 
ir. G. Dallinga-Thie van de Erasmus Universiteit te Rotterdam; dr. L. Havekes 
van het Gaubius Instituut TNO te Leiden en dr. Marinkovic van het Binnengast-
huis te Amsterdam. De vakgroep Experimented Diermorfologie en Celbiologie 
dank voor de gastvrijheid voor het maken van rbntgenfoto's. 
De co-auteurs van de artikelen, die in dit proefschrift zijn opgenomen zeg 
ik dank voor de waardevolle diskussies die aan de totstandkoming van de artike-
len vooraf gingen. 
Het typewerk was in de bekwame handen van Riet Hoogkamer-Weijman, Riekie 
v.d. Molen-Janssen en Gerfriede Hoekendijk-de Wal. 
De illustraties in de bijlage werden op prettige wijze verzorgd door 
Loet van Moll. 
Alle anderen die op een of andere wijze aan het onderzoek hebben bijgedra-
gen en hier niet met name genoemd zijn wil ik bij deze ook bedanken. 
Summary 
This thesis deals with the effect of type and amount of dietary fat on the 
concentration and composition of serum lipoproteins, colonic function, plasma 
glucose and serum insulin levels and blood pressure in healthy human volunteers. 
Two experiments were carried out. In the first experiment with 60 
volunteers a moderate fat diet with a high proportion of polyunsaturated fatty 
acids (as recommended by several advisory bodies), was compared with three 
other diets during a test period of 5 weeks. One diet was low in total fat with 
a low proportion of polyunsaturated fatty acids, one diet was high in total fat 
with a high proportion of polyunsaturated fatty acids and one was high in total 
fat with a low proportion of polyunsaturated fatty acids. In the second experi-
ment with 35 volunteers the moderate fat diet rich in polyunsaturated fatty 
acids and the low fat, low polyunsaturated fatty acid diet were compared again, but 
this time the test period lasted 13 weeks. The diets were composed of regular 
foodstuffs and differed in carbohydrate and fat content or fatty acid composi-
tion only. There were only minor differences in intake of dietary fiber and 
other nutrients known to affect cholesterol metabolism. 
Subjects in both studies were under strict dietary control. All foodstuffs, 
except for 100 kcal (0,4 MJ) per day were supplied individually according to 
each person's energy need. Actual food intake was measured by food records and 
analysis of double portions. The fatty acid composition of cholesterol esters 
in serum was analysed in the second experiment in order to check adherence to 
the diets. 
The serum lipoprotein composition and concentration observed during the 
experiments are given in Chapters 2 and 3. In serum, total cholesterol, trigly-
cerides, apolipoprotein-Aj and -B were measured; in high-density-lipoprotein 
(HDL), cholesterol was measured; in low-density-lipoprotein (LDL), cholesterol 
and triglycerides were measured and in very-low-density-lipoprotein (VLDL), 
triglycerides, apolipoprotein-B and the apolipoprotein-Crj/Cjjjratio were 
measured. From these experiments two conclusions can be drawn. Firstly, that 
both a low fat diet, low in polyunsaturated fatty acids and a moderate fat diet, 
high in polyunsaturated fatty acids lower total serum cholesterol levels when 
compared with the habitual diet of affluent communities. Secondly, that a low 
fat diet causes lower HDL-cholesterol and higher fasting VLDL-triglyceride 
levels than a moderate fat diet, high in polyunsaturated fat. 
It is by no means certain that changes in the concentration of HDL and 
VLDL really result in changes in the risk of death from cardiovascular 
diseases. In long-term intervention trials, such a hypothesis has not been 
tested; only the effect of changes in serum total cholesterol has been studied 
in intervention trials. 
Chapter 4 deals with effects on colonic function. No changes in mean transit 
time through the gut, fecal wet and dry weight, frequency of stools and con-
centration of fecal steroids were found. This shows that the intake of dietary 
fiber had been roughly equal in all diet groups within each experiment. 
Because there were no consistent short- or long-term changes in fecal bile acid 
or neutral steroid excretion, it is concluded that changes at the intestinal 
level do not explain the changes in total serum cholesterol concentration. 
Chapter 5 gives the results of measurements of fasting and postprandial 
serum insulin and glucose concentrations. The results show, that neither the 
amount nor the type of dietary fat had a strong influence on these variables 
in healthy subjects. 
Chapter 6 describes the effect of type and amount of dietary fat on blood 
pressure as well as the effect of dietary fiber from various sources and type 
of protein. None of these dietary components had a demonstrable effect on blood 
pressure in young normotensive subjects. 
The results of these experiments do not call for changes in the dietary 
recommendations of the Netherlands Nutrition Council, as far as the risk of 
death from cardiovascular diseases is concerned. 
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1. Introduction 
This thesis deals with the effect of the type and amount of dietary fat on 
a number of risk indicators for cardiovascular diseases. Cardiovascular diseases 
are the cause of death for 45% of all people who die each year in the Nether-
lands. Thirteen percent of deaths from cardiovascular diseases occur in people 
before the age of 60 years and 8 percent between the age of 60 and 65 years. 
Within the broad category of cardiovascular diseases, ischemic heart diseases 
and cerebrovascular diseases account for 75% of all deaths. Mortality from these 
diseases is four to six times greater in men below the age of 60 than in women 
of similar age. Of the people who cease work for health reasons each year, 19% 
do so because of cardiovascular diseases (1, 2). 
The principal cause of ischemic heart diseases and cerebrovascular diseases 
is atherosclerosis. A number of hypotheses concerning the pathogenesis of 
atherosclerosis have been proposed (3) but the most important within the scope 
of this introduction is the 'response-to-injury' hypothesis (4). 
The 'response-to-injury' hypothesis 
To understand this hypothesis one must recall that normal arteries are 
composed of three layers or tunicas as outlined in Figure 1. 
External 
Elastic 
Lamina Adventitia 
Figure 1. The structure of a small artery,free of atherosclerosis 
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The inner layer is the tunica intima; the endothelial lining which provides a 
smooth, low friction, inner surface in contact with the blood stream. The 
tunica media is a thick middle layer composed of smooth muscle and elastic 
fibers intermingled and arranged both lengthwise and circumferentially. The 
outer layer, the tunica adventitia, is formed by fibrous collagenous tissue. 
According to the 'response-to-injury' hypothesis factors such as hyperlipidemia, 
the increased stress in hypertension, carboxyhaemoglobin (resulting from 
cigarette smoking) and a number of other factors may 'injure' the endothelium. 
This alters the nature of the endothelial barrier to the passage of blood 
constituents into the arterial wall and possibly causes focal desquamation of 
the endothelium, resulting in exposure of the underlying intimal connective 
tissue. This is followed by adherence of platelets to subendothelial collagen, 
after which microthrombi are formed by platelet aggregation. The platelets then 
release the contents of their granules. The massive infiltration of platelet 
factors, plasma lipoproteins and possibly other plasma constituents at the site 
of injury leads to the focal proliferation of arterial smooth muscle cells, the 
formation of large amounts of connective tissue matrix by these cells and to 
the deposition of lipids both within the cells and in their surrounding 
connective tissue matrix. If the injury occurs only once, the lesion may heal 
and regress leaving a slightly thickened intima. Repeated or chronic injury to 
the endothelium may lead to a complicated lesion protruding into the arterial 
lumen. In such a lesion, deposition of lipid would occur, smooth muscle cells 
would proliferate, and connective tissue would be laid down and eventually the 
whole lesion would become rigid as a result of calcification. This sequence of 
events could lead ultimately to such clinical symptoms as angina pectoris or 
infarction, resulting from the lesion obstructing the artery or from a thrombus 
lodging in the partially obstructed artery. 
Risk factors 
Many epidemiological studies have been carried out to explore the 
characteristics of people or the environment in which they live in relation to 
the risk of developing cardiovascular diseases. A number of factors have been 
found to be associated with such risk and these can be classified, as suggested 
by Stamler and coworkers (5), as follows: 
- those involving social environment and life style, e.g. a habitual diet high 
in saturated fats, cholesterol, and energy, cigarette smoking; sedentary 
living. 
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- those involving endogenous biochemical and physiological regulatory 
mechanisms, but amenable to exogenous influences such as diet or pharma-
ceuticals. Examples of such endogenous mechanisms are: hyperlipoproteinemia, 
hypertension, diabetes, hyperglycemia, hyperuricemia, and rapid resting heart 
rate. 
- those involving organ pathology, e.g. ECG abnormalities, hypothyroidism, and 
renal disease. 
- those involving fundamental biological properties not generally amenable to 
exogenous influences, e.g. age, sex, heredity. 
Some of these factors occur simultaneously and are often interrelated. 
From multivariate analysis (6) of data from several studies it became apparent 
that most of the risk for developing cardiovascular diseases can be predicted 
from three factors; hypercholesterolemia, cigarette smoking and hypertension. 
From the foregoing explanation of the 'response-to-injury' hypothesis it can be 
seen that these factors might also be causally involved in the proces of 
atherogenesis. In long-term intervention trials reduction of both hyperchole-
sterolemia and hypertension have been shown to lower mortality from cardio-
vascular diseases (7-10). 
In recent years is has become clear that not only is the total serum chole-
sterol concentration important, but that the cholesterol distribution between 
the various lipoprotein fractions is also important. Over the last two decades 
prospective epidemiological studies have shown that the risk of cardiovascular 
diseases increases with increasing plasma concentrations of total cholesterol 
and also low density lipoprotein (LDL) cholesterol (11) and decreases with 
increasing concentrations of high density lipoprotein (HDL) cholesterol (12-14). 
There are indications that LDL promotes deposition of cholesterol in the 
arterial wall, while HDL does the reverse. It should be noted however that in 
affluent societies, the level of serum total cholesterol mainly reflects the 
concentration of LDL-cholesterol. 
A controversy still remains about the possible benefits of lowering serum 
cholesterol concentrations. This may arise partially from misunderstandings 
about what can be expected in terms of lowering the risk of cardiovascular 
diseases. Thus, an example will be given of an estimate of the possible benefit 
of lowering serum cholesterol concentrations on the incidence of myocardial 
infarction. The estimate, which can only be calculated for groups of persons on 
average, was made by Whyte (15) based on data from the Framingham Study, which 
is a large population study in the United States. Whyte calculated that if 100 
men who are non-smokers, with normal blood pressure and electrocardiogram, 
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lower their plasma cholesterol from 8 to 6.7 mmol/1 starting at 35 years of age, 
6 could potentially benefit by avoiding a coronary incident before the age of 
55, 94 would be likely to follow the regimen without apparent benefit, and 8 of 
these would have an attack within 20 years despite adherence to the regimen. 
The potential benefit is less for women and for those who start the regimen at 
an older age. It is greater if cholesterol is lowered further and if other risk 
factors are present: for instance, 29 of 100 men starting at age 35 who are 
cigarette smokers with moderate hypertension and left-ventricular hypertrophy 
and who reduce their plasma-cholesterol concentration from 8 to 5.4 mmol/1 
would benefit. 
These examples show that lowering the concentration of serum cholesterol does 
not give 100% protection against cardiovascular diseases but also that the 
protection bestowed is not negligable. Thus recommendations, including 
recommendations concerning diet, aimed at reducing the incidence of ischemic 
heart diseases in particular and cardiovascular diseases in general have been 
drawn up by authorities in a number of countries. 
Dietary recommendations 
Dietary factors, especially saturated fatty acids and cholesterol influence 
the risk of cardiovascular diseases probably via their effect on the level of 
cholesterol in serum but perhaps also through other factors such as blood 
pressure and blood clotting. A controversy still exists about which type of 
diet should be recommended to the general population for the optimalization of 
serum lipid levels. The Netherlands Nutrition Council (16) recommends a diet 
moderate in total fat (33% of daily energy) in which the ratio of saturated, mono-
unsaturated and polyunsaturated fatty acids is 1 : 1 : 1. However, objections 
have been raised against recommending diets rich in polyunsaturated fatty acids 
since there has been no long-term experience with such diets on a large scale. 
As an alternative, lowering the consumption of total fat has also been proposed 
(17). Since the effects of such diets on serum lipids have been studied much 
less thoroughly than those of diets rich in polyunsaturated fatty acids, two 
studies were carried out. 
Experiments described in this thesis 
In this thesis the results of these studies are reported. In the first 
experiment a diet containing a moderate amount of fat rich in polyunsaturated 
fatty acids, as recommended by the Netherlands Nutrition Council was compared 
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with 3 other diets during a test period of 5 weeks; a high carbohydrate diet, 
low in fat which was low in polyunsaturated fatty acids and two high fat diets, 
one high and one low in polyunsaturated fatty acids. 
In the second experiment, the high carbohydrate low fat diet and the moderate 
fat 'recommended' diet were compared again, but this thime the test period 
lasted 13 weeks. 
In both studies, the diets differed only in the proportion of carbohydrate and 
fat present and in the fatty acid composition of the fat. The dietary intake of 
the participants was strictly controlled. Relatively large numbers of partici-
pants were involved in the studies; in the first experiment there were 60 people, 
and in the second, 35. The subjects were healthy young male and female students 
who volunteered to participate in the study. 
Five publications resulting from this work are reproduced in this thesis. 
The first two papers (Chapters 2 and 3) describe the composition and concentra-
tion of the lipoproteins in the two experiments. Chapter 4 deals with the 
effects of the type and amount of dietary fat on colonic function. In Chapter 5, 
the fasting and postprandial serum insulin and glucose concentrations in both 
experiments are presented. Finally, Chapter 6 deals with the influence of 
various dietary factors on blood pressure. 
The overall conclusions were that a low fat diet, low in polyunsaturated 
fatty acids and a moderate fat diet high in polyunsaturated fatty acids both 
lower total serum cholesterol levels when compared with the habitual diet of 
affluent communities. However, the low fat diet produced lower HDL-cholesterol 
levels and higher fasting VLDL-triglyceride levels than the recommended 
moderate fat diet high in polyunsaturated fatty acids. It may well be that many 
low fat diets consumed by people in the community differ in their composition 
from the one used here and thus may not produce the adverse effects on the 
concentration of HDL-cholesterol and VLDL-cholesterol as observed in the 
experiments described. 
Changes in total serum cholesterol concentrations could not be explained by 
changes in the fecal excretion of degradation products of cholesterol. 
Neither the type nor the amount of dietary fat had a demonstrable effect on 
blood pressure or serum glucose or insulin levels in the young healthy men and 
women studied in these experiments. 
The results do not call for changes in the dietary recommendations of the 
Netherlands Nutrition Council, at least as far as risk of death from cardio-
vascular diseases is concerned. 
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Summary 
We have studied whether a low-fat diet is as effective in lowering some risk 
factors for atherosclerosis as a diet rich in polyunsaturated fat (PUFA). During 
a 2.5 week control period, 60 volunteers were given a moderate-fat diet (MOD) 
providing 30% of the daily energy intake (energy %) in the form of fat, one-
third of which was PUFA. For the next 5 weeks subjects were divided into 4 
groups and received diets providing varying amounts of total fat and of PUFA: 
for group LO, 20 energy % fat and 3 energy % PUFA; group MOD, 30 energy % 
fat and 11 energy % PUFA; group HIPUF, 40 energy % fat and 19 energy % 
PUFA; and group HISAT, 40 energy % fat and 3 energy % PUFA. The diets 
contained the same amounts of cholesterol, phytosterols, oligosaccharides and 
other nutrients, known to affect serum lipid levels. All food was prepared daily 
and weighed out for each individual appropriate to his energy needs. Nutrient 
intakes were checked by 7-day records and by chemical analysis of double 
portions. 
On diet LO, total serum cholesterol concentration increased by 0.25 
mmol/1 while HDL cholesterol concentration did not change significantly. The 
This work was supported by The Netherlands Heart Foundation, Grant 77.082. 
Correspondence to: J. Brussaard, Agricultural University, Department of Human Nutrition, De Dreijen 
11, 6703 BC Wageningen, The Netherlands. 
Abbreviations: CVD, cardiovascular disease; HDL, high density lipoprotein; LDL, low density lipopro-
tein; VLDL, very low density lipoprotein; PUFA, polyunsaturated fatty acids; energy %, percent of daily 
energy intake. 
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HDL cholesterol/apoprotein-A; ratio fell, and VLDL and LDL triglyceride con-
centrations were elevated. 
On the HIPUF diet, total serum cholesterol concentration was not signifi-
cantly lower, but HDL cholesterol concentration increased by 0.10 mmol/1. On 
the HISAT diet, total serum cholesterol concentration went up by 0.38 
mmol/1; 0.12 mmol/1 of this was due to HDL. 
LDL cholesterol/serum apoprotein-B ratios were unaffected by any of the 
diets. 
It was concluded that after 5 weeks, the influence of a low-fat, high-carbohy-
drate diet on the concentrations of serum lipoproteins was less favourable than 
that of moderate- or high-fat diets rich in polyunsaturated fatty acids. 
Key words: Apolipoproteins — Carbohydrates — Dietary fat — HDL cholesterol — Linoleic 
acid — Serum cholesterol 
Introduction 
During the last two decades, prospective epidemiological studies have shown 
that the risk of cardiovascular disease (CVD) increases with increasing plasma 
concentrations of total or LDL cholesterol [1] and decreases with increasing 
HDL cholesterol [2—4]. Plasma HDL cholesterol concentration is reduced in 
several conditions associated with an increased risk of future CVD namely 
hypercholesterolemia, hypertriglyceridemia, obesity and diabetes mellitus 
[5,6]. Subjects with existing clinical atherosclerotic disease also have lower 
levels of HDL than healthy subjects within the same community [5,7,8]. 
In order to elucidate the metabolic origin of differences in lipoprotein lipid 
levels interest has focussed recently on the measurement of the apolipoproteins 
of LDL and HDL. Apo-B, the main apoprotein of plasma LDL, is substantially 
increased in the plasma of subjects with hypercholesterolemia, while 
endogenous hypertriglyceridemia is associated with a mild increase in plasma 
levels of apo-B [9,10]. In the latter instance the increase in serum apo-B is 
mainly located in the VLDL fraction. 
Apo-A,, the main apoprotein of plasma HDL, is found to be reduced in 
survivors of myocardial infarction as compared with controls [11] and the 
HDL cholesterol/apo-Ai ratio was also lower in this condition [8] . At the other 
end of the risk scale, HDL cholesterol/apo-Aj ratios were higher in a low-risk 
group of vegetarians than in a control group [12]. 
Many short-term experiments have shown that on diets in which saturated 
fat is replaced by polyunsaturated fat the serum cholesterol and triglyceride 
levels are lowered; in long-term intervention trials a reduction in the incidence 
of cardiovascular disease was also noted [13,14]. As a result of such studies, 
diets high in polyunsaturated fat have been advocated for the prevention of 
CVD, and consumption of vegetable oils in the U.S. has indeed risen consider-
ably during the last decade [15]. There are fewer controlled studies in man on 
the effect of replacing saturated by polyunsaturated fat on the concentration 
and composition of separate lipoproteins, while studies on the effect of natural 
low-fat diets in healthy subjects are quite rare. 
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We have investigated the effects of a low-fat diet on serum lipids, lipoprotein 
composition, blood pressure and faecal steroids as compared with a moderate-
fat, high-polyunsaturated diet, containing the same amounts of cholesterol and 
other nutrients that may affect serum lipid levels. In the present paper results 
of lipoprotein, apo-Ai and apo-B analyses will be presented. 
Subjects and Methods 
Selection of subjects 
Thirty-seven male and 23 female university students, aged 18—28 years 
participated in this study. The subjects were all volunteers who satisfied the 
following criteria: 
apparently healthy, as judged by a detailed questionnaire; 
serum cholesterol concentration below 5.7 mmol/1; 
serum triglyceride concentration below 1.7 mmol/1; 
diastolic blood pressure below 90 mm Hg; 
percentage of body fat below 23% in males and 30% in females as deter-
mined by skin fold measurements. 
Only two of the females used hormonal anticonception. 
Experimental design, diets and control of food intake 
During the first 2.5 weeks of the study all subjects consumed a control diet 
(MOD) which was moderate in fat and relatively high in PUFA (30 energy % 
total fat, 10 energy % PUFA) in agreement with the recommendations of The 
Netherlands Nutrition Council. After this period, 4 subgroups were formed 
which received diets as presented in Fig. 1. The groups were matched for initial 
serum cholesterol, energy intake and sex. Mean body weights per group were 
67.2, 66.6, 64.9 and 66.0 kg for groups LO, MOD, HIPUF and HISAT 
respectively. Throughout the 8-week period all foodstuffs were weighed out for 
each person in quantities appropriate to his energy needs, except for 100 kcal/ 
day, which the subjects were free to spend at will. Average energy intake during 
the control period was 11.1 ± 3.6 MJ (±1 SD) (2643 ± 854 kcal). Actual 
nutrient intakes were checked by 7-day individual food records using Dutch 
food composition tables [16] , and by double-portion analysis [17] for one 
imaginary person of average energy intake on each diet. Mean daily intakes on 
nutrients are given in Table 1. Analysis of double portions revealed a slightly 
Con t ro l 
Time ( w e e k s ) 0 2 
I L 
Test P e r i o d 
4 6 8 
_1 I I 
TT T T TT 
L0 Group (n = 16) MOD Die t LO Diet 
MOD Group (n =15) [MOD Diet I MOD Diet 
HIPUF Group (n=15) MOD D ie t HIPUF Diet 
HISAT Group(n = U ) MOD D i e t T HISAT Diet 
Fig. 1. Experimental design. Blood sampling is indicated by arrows. 
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TABLE 1 
MEAN DAILY INTAKE OF NUTRIENTS ACCORDING TO INDIVIDUAL FOOD RECORDS a 
Energy (MJ) 
(kcal) 
Protein (energy %) 
vegetable 
animal 
Total fat (energy %) 
saturated 
monounsaturated 
polysaturated 
Carbohydrates (energy %) 
sugars 
polysaccharides 
Alcohol (energy %) 
Vitamin C (mg) 
Cholesterol (mg/1000 kcal) 
Phytosterols (mg/1000 kcal) e 
Dietary fiber (g/1000 kcal) 
Habitual 
intake 
before 
experiment *> 
11.4 
2734 
13 
6 
7 
32 
15 
11 
5 
50 
24 
27 
4 
109 
106 
15.0 
Control c 
period 
MOD 
11.1 
2646 
14 
7 
7 
30 
10 
8 
11 
54 
22 
32 
1 
110 
114 
160 
10.0 
Experimental period d 
LO 
10.6 
2517 
13 
6 
7 
22 
8 
10 
3 
64 
21 
43 
0 
100 
102 
98 
9.7 
MOD 
10.5 
2517 
14 
7 
7 
30 
10 
8 
11 
54 
21 
33 
1 
103 
113 
158 
9.4 
HIPUF 
10.7 
2552 
14 
7 
7 
40 
11 
8 
19 
44 
21 
23 
1 
100 
104 
107 
9.7 
HISAT 
10.3 
2455 
13 
6 
6 
39 
18 
16 
3 
46 
23 
23 
2 
107 
86 
214 
10.5 
a
 The food records were elaborated using the Netherlands food composition tables. 
b 3-day records. 
c
 2-day records. 
°- 5-day records. 
e
 Measured by analysis of duplicate portions providing 2700 kcal/day. 
higher proportion of fat in the total daily energy intake in all groups, but the 
differences between groups in fat intake, fatty acid composition and other 
nutrients agreed well with the food records. Body weight was recorded weekly. 
Energy intake was adjusted when necessary in order to avoid changes in body 
weight of more than 2 kg. 
The mean change per group in body weight over the 5 weeks of the test 
period ranged from —0.4 ± 1.1 to —0.8 ± 1.4 kg. 
Stools were collected for 7 days at the end of the control and the test 
periods. There were no differences between the groups in intestinal transit time 
[18], faecal output and moisture content or frequency of stools in either 
period. 
Blood sampling and analysis 
Blood samples were taken after an overnight fast before and during the 
experimental period as indicated in Fig. 1. No alcohol was allowed during 24 h 
prior to blood sampling. Serum was obtained by low-speed centrifugation. 
Serum cholesterol was measured according to Huang et al. [19] using serum 
calibrators calibrated as described by Abell et al. [20]. Reproducibility for 
blind control sera provided by the Center for Disease Control, Atlanta, GA, 
U.S.A., was ±0.9% and accuracy was within 1.4% of the "true" (target) values. 
HDL cholesterol was determined after manganese-heparin precipitation of 
apo-B containing lipoproteins [21] as previously described [22] . At the end of 
the control and the test periods, sera were collected for apolipoprotein-A! and 
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Fig. 2. Coomassie-blue stained immunoprecipitates (rockets) of a pooled human serum with anti-Aj (A) 
and anti-B (B) goat serum. Conditions of the electroimmunoassay were : (A) 2.0% goat anti-human 
apo-Aj serum; antigen wells 1—6 contained 15 Ml human serum diluted with 150 mM NaCl (1 plus 119, 1 
plus 74, 1 plus 54, 1 plus 42, 1 plus 34 and 1 plus 29 respectively). Surface area/dilution, r - 0.999. (B) 
0.5% goat anti-human apo-B serum; antigen wells 1—4 contained 15 /il diluted human serum (1 plus 16, 
1 plus 8, 1 plus 6, and 1 plus 4 respectively). Surface area/dilution, r - 0 .998. 
B determinations and for lipoprotein fractionation by the procedure of Red-
grave et al. [23] with several modifications. To visualize the lipoprotein bands 
after ultracentrifugation, 3 ml serum was mixed with 0.3 ml 0.02% (w/v) Sudan 
Black (Difco Laboratories) dissolved in dimethylsulphoxide. The background 
density of the mixture was raised to 1.210 with solid KBr (0.9552 g). On top 
of the serum a discontinuous density gradient was built up in a centrifuge tube 
(14 X 89 mm, 13 ml) with salt solutions of d = 1.063 (4.5 ml) followed by d = 
1.006 (4.5 ml). These salt solutions contained EDTA (0.1 mg/ml) and were 
prepared from NaCl and KBr [24]. Centrifugation was carried out at 20° C and 
40 000 rpm (RCFm a x = 272,700 Xg) for 16 h and the clearly visible bands of 
VLDL, LDL and HDL were harvested by tube slicing [25]. Lipoprotein choles-
terol concentrations were determined according to Abell et al. [20] . Serum 
VLDL and LDL triglyceride concentrations were measured as described by 
Soloni[26] . 
Apoproteins were measured in whole serum by rocket Immunoelectro-
phoresis [27] (see Fig. 2). Monospecific antisera against human apoprotein-B 
and apoprotein-Aj were raised in goats using pure apo-B in LDL (1.040 < d < 
1.053 mg/ml) and pure apo-A[ [28,29] as antigens. Electrophoresis was 
performed at pH 8.6 using 0.8% agarose (apo-B assay) or 0.8% agarose, 5% 
dextran T 10 (apo-Aj assay) in 50 mM diethylbarbiturate buffer as supporting 
medium for the antisera. 
The electrophoresis was performed at 2.5 V/cm for 16 h (apo-B) or at 3.5 
V/cm for 10 h (apo-Aj). Serum samples were analysed in three dilutions. For 
one subject the samples obtained at the start and at the end of the test period 
were always analysed on one plate in order to minimise the effect of inter-assay 
variability. Because isolated LDL solutions become turbid during prolonged 
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preservation, day to day calibration standards of a pooled serum were prepared 
in four dilutions. The apo-B and apo-Ai contents in this secondary calibration 
standard were determined with freshly isolated pure LDL and pure apo-Aj and 
redetermined periodically. The protein content in the primary standards was 
determined by quantitative amino acid analysis. Analytical error was monitored 
by analysing a sample from a control pool on each plate. The combined within-
day and between-day coefficients of variation for this control serum were 7% 
and 9% for the apo-B and the apo-A, assays respectively. 
Statistical evaluation 
The individual values at the beginning and the end of the test period were 
compared per group, using a paired two-tailed t-test. Each subject thus served 
as his own control. 
Results 
The time courses of serum total cholesterol, serum total triglycerides and 
HDL cholesterol are presented in Figs. 3, 4 and 5 respectively. 
All groups received the moderate fat, high PUFA MOD diet for the initial 2.5 
week control period. By this time the mean serum total cholesterol concentra-
tion had decreased significantly by 0.46 mmol/1 (Fig. 3), of which 0.06 mmol/1 
was located in HDL (Fig. 5). Serum total triglycerides had decreased by 0.12 
mmol/1 (Fig. 4). Although the groups were matched for initial total serum cho-
lesterol there were slight differences in initial values of HDL cholesterol and 
total serum triglycerides (Figs. 3 and 4). However, neither these initial values 
nor the changes in these parameters during the control period differed signifi-
cantly between the groups. When the subjects changed from the MOD diet to 
the test diets, the concentrations of serum cholesterol remained unchanged in 
groups MOD and HIPUF and increased significantly in groups LO and HISAT, 
by 0.25 and 0.38 mmol/1 respectively. HDL cholesterol concentration was 
unchanged in groups LO and MOD, but increased significantly in groups HIPUF 
and HISAT, by 0.10 and 0.12 mmol/1 respectively. Total triglyceride concen-
(mmol/l) 
4 .5 - Control 
4 .0 -
3.5 
I 
_ L _ L 
140 
0 2 4 6 8 
WEEKS 
Fig. 3 . Mean total serum cholesterol concentrations during the experiment. • 
MOD; • • , HIPUF; • • , HISAT. Vertical bars indicate 1 SEM; an asterisk denotes a significant 
difference (/• < 0.05 or 0.01) from the value at the end of control period. 
LO; o -
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CONTROL TEST PERIOD 
100 
Fig. 4. Mean total serum triglycerides during the experiment. • • , LO; o o, MOD; o o, 
HIPUF; • a, HISAT. Vertical bars indicate 1 SEM; an asterisk denotes a significant difference (P < 
0.05 or 0.01) from the value at the end of control period. 
tration increased significantly in group LO by 0.35 mmol/1 and in group MOD 
by 0.11 mmol/1. 
Data for lipoprotein lipids and serum apolipoproteins are presented in Tables 
2, 3 and 4 respectively. In all groups HDL cholesterol and serum apo-Ai con-
centrations were slightly but not significantly higher for females than for males. 
As HDL cholesterol was unchanged in group LO the rise in total serum cho-
lesterol in this group was entirely located in the LDL and VLDL fractions (0.38 
and 0.09 mmol/1 respectively). This was accompanied by an increase of 118 ± 
60 mg/1 in serum apo-B concentration, but the LDL/apo-B ratio remained the 
same (Table 4). Although HDL cholesterol remained constant, HDL composi-
tion changed as judged by the HDL cholesterol/apo-Aj ratio, which decreased 
significantly (Table 4). VLDL triglycerides increased significantly by 0.14 
mmol/1 and LDL triglycerides by 0.08 mmol/1 (Table 2). 
The MOD group, which continued on the control diet during the test period, 
Control Test Period 
70 
60 . 
50-
40 
WEEKS 
Fig. 5. Mean serum HDL cholesterol during the experiment, a a, LO; o o. MOD; n a, 
HIPUF; a a, HISAT. Vertical bars indicate 1 SEM; an asterisk denotes a significant difference (P < 
0.01 or 0.05) from the value at the end of control period. 
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TABLE 3 
CONCENTRATIONS IN SERUM OF APOLIPOPROTEIN-Aj AND APOLIPOPROTEIN-B AT THE 
END OF THE CONTROL AND THE TEST PERIODS 
Values expressed as mean + SD 
Group 
LO 
MOD 
HIPUF 
HISAT 
apo-Aj (mg/1) 
Control 
1068 ± 1 5 1 
1089 ± 1 5 0 
1271 ± 1 2 7 
1178 ± 205 
Test 
1138 ± 149 ** 
1201 ± 149 ** 
1295 ± 1 0 9 
1278 ± 162 ** 
apo-B (mg/1) 
Control 
627 ± 1 6 3 
544 ± 143 
580 ± 1 0 3 
664 ± 202 
Test 
732 ± 165 ** 
541 ± 1 2 2 
574 ± 120 
718 ± 175 ** 
* * P < 0 .01; significantly different from control period according to paired two-tailed f-test. 
The correlation coefficient between LDL cholesterol and serum apo-B was r = 0.87 (n = 60); the corre-
lation coefficient between HDL cholesterol and serum apo-Aj was r = 0.58. Rather low correlation coeffi-
cients between serum apo-Aj and HDL cholesterol in normolipemics have also been published'by other 
authors [28,45—47]. 
showed very little change. Although serum total and HDL cholesterol concen-
tration remained unchanged, the HDL cholesterol/apo-A! ratio decreased signif-
icantly. Total triglycerides increased by 0.11 mmol/1, after an initial decrease of 
0.11 mmol/1 in the control period (Fig. 4). 
Surprisingly, the effects of the HIPUF diet, in which an additional 10 energy 
% of carbohydrates had been replaced by PUFA, did not differ greatly from the 
MOD diet. Total serum cholesterol remained reasonably constant compared 
with during the control period, but HDL cholesterol increased significantly by 
0.10 mmol/1 (Fig. 5). There was a minor increase in the HDL cholesterol/ 
apo-A! ratio (Table 4). Total triglycerides decreased significantly by 0.13 
mmol/1 (Fig. 4); this decrease mainly took place in VLDL (0.09 mmol/1). 
The high-fat low-PUFA diet caused a significant increase in serum cholesterol 
concentration. It is noteworthy, however, that of the total increase of 0.38 
mmol/1, about 30% was accounted for by HDL. Total serum triglycerides 
TABLE 4 
CHOLESTEROL/APOLIPOPROTEIN RATIOS AT THE END OF THE CONTROL AND THE DIETARY 
TEST PERIODS 
Apoprotein values are for whole serum. HDL cholesterol was determined after manganese-heparin precipi-
tat ion and LDL cholesterol after density gradient centrifugation. Values expressed as mean ± SD. 
Group 
LO 
MOD 
HIPUF 
HISAT 
HDL cholesterol/ap 
Control 
1.13 ± 0.19 
1.22 ± 0.18 
1.05 ± 0.17 
1.14 ± 0 . 1 2 
o-Ai (mmol/g) 
Test 
1.07 ± 0.18 * 
1.13 ± 0.15 * 
1.11 ± 0.14 * 
1.15 ± 0.11 
LDL cholesterol/apo 
Control 
3.2 ± 0.5 
_ a 
3.3 ± 0.3 
3.1 ± 0.6 
-B (mmol/g) 
Test 
3.2 ± 0.5 
a 
3.4 ± 0.4 
3.2 ± 0.3 
a
 Not measured. 
* P < 0 ,05; significantly different from control period according to paired two-tailed t-test. 
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increased by 0.07 mmol/1, and serum apo-B concentration by 54 mg/1 
(Table 3). 
In all groups, the LDL cholesterol/apo-B ratio remained constant as 
compared with the control period (Table 4). 
Discussion 
Participants in this study were well-motivated, normolipidemic students of 
the Agricultural University. We have repeatedly found [17,30] that the fat and 
cholesterol consumption in this population is lower than the average intake in 
this country (Table 1). Thus the change from 'habitual' diet to the rigidly 
controlled MOD diet in the control period of our study mainly involved an 
increase in the P/S ratio (Table 1). The observed decrease in serum cholesterol 
and triglycerides is in agreement with earlier studies [31], although the fall in 
total cholesterol is somewhat larger than expected [31]. This could be due to 
adaptation to laboratory conditions and to an inaccurate estimation of their 
habitual fat intake. 
At this level of fat intake (30% of energy), our data showed a decrease in 
HDL cholesterol on the high P/S diet, a result previously described by 
Shepherd et al. [32] in dietary studies in normo- and hyperlipidemic men. 
However, as discussed below, we were unable to demonstrate such a change 
under controlled conditions at a higher fat intake level (40% of energy). 
The effects of a change from MOD to LO, HIPUF and HISAT diets on serum 
lipoproteins were studied under rigidly controlled conditions as was the effect 
of prolonged consumption of the MOD diet. In the latter (MOD) group no 
changes in serum total cholesterol, HDL cholesterol and serum apo-B concen-
trations were observed between 3 and 8 weeks, indicating that these parameters 
were stabilised already by the end of the control period. However, this was not 
the case for HDL composition as serum apo-A] concentrations rose signifi-
cantly during the test period. 
Changing from the MOD to the LO diet involved a replacement of 8 energy 
% PUFA by carbohydrates. VLDL increased significantly by this treatment, 
probably by carbohydrate-induced synthesis [33,34] which may have been 
reinforced by the decrease in PUFA. 
A pertinent finding was the increase in LDL, reflected by the simultaneous 
rise in LDL cholesterol and serum apo-B concentrations (+17%). Whether the 
rise in LDL is mediated by an increased conversion of VLDL into LDL [36— 
38] or by a delayed LDL degradation [39] (the phospholipid moiety of LDL 
may be more saturated on this carbohydrate-rich diet [35]) is at present not 
known. 
One might speculate that the decreased HDL cholesterol/apo-A! ratio in the 
LO group reflected a shift from the cholesterol-rich HDL2 fraction to the 
HDL3 fraction [42] . 
Changing from the MOD to the HIPUF diet implied that 8 energy % of 
carbohydrates were replaced by PUFA. The further increase in dietary linoleic 
acid did not cause significant changes in LDL and VLDL cholesterol values or 
serum apo-B. Although this indicates that the HIPUF diet was no more 
effective in depressing serum LDL levels than the MOD diet, total serum 
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triglycerides decreased on the HIPUF diet and a significant rise in HDL 
cholesterol was observed, which was not accompanied by an increase in serum 
apo-A, concentration. 
On changing from the MOD to the HISAT diet, 8 energy % PUFA plus 8 
energy % carbohydrates were both replaced by saturated fat resulting in a 
significant increase in serum LDL concentrations judged from the proportional 
change in LDL cholesterol and serum Apo-B concentrations. HDL cholesterol 
as well as serum apo-At concentrations were also significantly increased. At this 
level of fat intake (40 energy %), no differences in HDL cholesterol and apo-A[ 
concentrations between the HISAT and the HIPUF diet were present. Lower 
VLDL and LDL levels on PUFA-rich diets such as MOD and HIPUF, compared 
with saturated fat-rich diets, such as HISAT, have been reported repeatedly. 
VLDL synthesis and conversion into LDL may be decreased on high P/S diets 
[36—38] although a recent report points to increased LDL catabolism [39] . 
Although different amounts and types of fat in '•he diet will also affect post-
prandial chylomicron production [40], it is unlikely that this will lead directly 
to changes in serum LDL concentrations. Small quantities of LDL can indeed 
be formed by chylomicron degradation but it can be calculated that the contri-
bution of this pathway to the overall LDL synthesis is very limited. 
Potential effects of diet on serum HDL are important since serum HDL cho-
lesterol concentrations have been inversely correlated with risk of cardio-
vascular disease [2—4]. Recently the effect of a diet rather similar to our MOD 
diet on serum HDL cholesterol concentrations in hyperlipidemic subjects has 
been studied by Hjermann et al. [41] and compared with a HISAT type diet. In 
this intervention study a 20% increase in HDL cholesterol on the MOD-type 
diet was observed after 4 years. However, it cannot be excluded that this rise 
was due to the decreases in serum triglyceride concentrations, obesity and 
cigarette smoking rather than to the diet. 
In addition to changes in HDL cholesterol, the average composition of HDL 
in our experiment was obviously sensitive to diet, although the changes were 
small. 
In order to illuminate the effects of the different diets, we calculated the 
ratio of the concentration of HDL cholesterol to total cholesterol and of 
apo-A, to apo-B (Table 5). If LDL is "atherogenic" and HDL is "anti-athero-
TABLE 5 
HDL/TOTAL CHOLESTEROL AND APO-Ai /APO-B RATIOS AT THE END OF THE CONTROL AND 
TEST PERIODS 
Values expressed as mean ± SD 
Group 
LO 
MOD 
HIPUF 
HISAT 
HDL/total cholesterol 
Control 
0.33 ± 0.07 
0.35 ± 0.07 
0.35 ± 0.06 
0.36 ± 0.06 
Test 
0.31 ± 0.08 ** 
0.36 ± 0.05 
0.38 ± 0.06 ** 
0.35 ± 0.05 
Apo-A i /Apo-B 
Control 
1.82 ± 0.55 
2.14 + 0.65 
2.24 ± 0.38 
1.93 ± 0.64 
Test 
1.67 ± 0.61 ** 
2.29 ± 0.41 
2.32 ± 0.37 
1.86 ± 0.42 
** P < 0 .01 ; significantly different from control period according to paired two-tailed t-test. 
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genie" then these ratios may have predictive value for atherogenic risks. On the 
HISAT diet the ratios showed surprisingly little change compared with the 
MOD diet. The low level of dietary cholesterol may have contributed to this 
result; there are indications [43] that satured fat and dietary cholesterol 
reinforce each other's effect on serum (LDL) cholesterol levels; the effects of a 
high saturated fat intake might have been more pronounced if the experiment 
had been performed at a higher level of cholesterol consumption. The HIPUF 
diet showed a trend towards more favourable ratios in contrast to the LO diet 
where unfavourable changes were observed. However, the latter could in part 
be due to the relatively short test period of 5 weeks. It is known that after 2—3 
months on high carbohydrate diets serum triglyceride concentration will go 
down again [44]. It is not known if similar long-term changes in HDL choles-
terol and apolipoproteins could appear; this should be investigated in long-term 
dietary studies. 
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SUMMARY 
In a controlled 16-week trial we have compared the effects on some risk 
factors for atherosclerosis of two cholesterol-lowering diets, one low in total 
fat and low in polyunsaturated fat (L0) and one moderate in total fat but high 
in polyunsaturated fat (MOD) as recommended by various advisory councils. 
Thirty-five volunteers were given diet MOD, during a 2.5 week control 
period. This provided 31% of the daily energy intake (energy%) as total fat, 
one-third of which was polyunsaturated fat (PUFA). The subjects were then 
randomized into 2 groups, one of which continued on diet MOD, while the other 
group received diet L0, providing 21 energy^ as total fat and 4 energy^ as PUFA. 
The diets contained the same amounts of cholesterol, phytosterols, oligosaccha-
rides and other nutrients known to affect serum lipid levels. All food was 
prepared daily and weighed out for each individual in amounts appropriate to 
his/her energy needs. Nutrient intakes were checked by 7-day records and by 
chemical analysis of double portions. VLDL plus LDL cholesterol decreased by 
0.66 mmol/1 during the control period while HDL-cholesterol level was unchanged. 
Total serum triglycerides decreased by 0.33 mmol/1. Total serum cholesterol 
increased by 0.21 ± 0.41 mmol/1 on the control diet MOD during the test period 
of 13 weeks. 0.09 ± 0.11 mmol/1 of this was due to HDL cholesterol. Total serum 
triglycerides remained constant during the test period in group MOD. 
On diet L0 total serum cholesterol remained stable during the test period, but 
HDL cholesterol was lowered by -0.06 - 0.20 mmol/1. The difference in HDL chole-
sterol between the diet groups was mainly located in HDL2. Total serum triglyce-
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rides increased by +0.32 ± 0.31 mrnol/1 in group L0; the increase in VLDL tri-
glycerides was 0.22 ± 0.18 mmol/1. 
The depression of HDL on diet LO was also reflected in the ratios of HDL to 
total cholesterol which decreased by -0.02 ± 0.05 and was unchanged on diets LO 
and MOD respectively and in the ratio of apo-Aj to apo-B (-0.17 ± 0.50 and 
constant on diets LO and MOD respectively). LDL-cholesterol/LDL-apo-B ratios 
were not affected by the diets. Combination of these data with those from a 
preceding study (Brussaard J.H. et ai., Atherosclerosis 36 (1980) 515) leads to 
the following conclusions: 
1. Both diets lower total serum cholesterol levels when compared with the 
habitual diets of affluent communities. 
2. The high-carbohydrate, low-fat diet causes lower HDL and higher fasting VLDL 
triglyceride levels than the recommended moderate fat-high PUFA diet. 
INTRODUCTION 
A controversy exists about which type of diet should be recommended to 
the general population for the optimalization of serum lipid levels. Diets high 
in linoleic acid have been shown to lower serum cholesterol and triglyceride 
levels; in long term intervention trials a reduction in the incidence of cardio-
vascular diseases was also noted (1, 2). However, objections have been raised 
against recommending diets rich in polyunsaturated fatty acids because there is 
no long term experience with such diets on a large scale. As an alternative, 
lowering of total fat consumption has been proposed (3). However, the effects 
of such diets on serum lipids have been studied much less thoroughly than those 
of PUFA-rich diets. 
We have recently reported (4) the effect of diets differing in type and 
amount of dietary fat on serum lipids and lipoproteins in young healthy 
volunteers during a test period of 5 weeks. It was found that replacing poly-
unsaturated fat by carbohydrates caused an increase in LDL cholesterol and 
serum apolipoprotein B concentration and a lowering of HDL-cholesterol. Total 
serum triglycerides and VLDL concentration increased, but it was uncertain 
whether this was a transient phenomenon. Antonis and Bersohn (5) also reported 
an increase of serum triglycerides on carbohydrate-rich diets, but the hyper-
triglyceridemia subsided after 3-4 months on this diet. 
In order to verify our earlier findings with respect to the effects on 
serum lipoproteins of replacing polyunsaturated fatty acids by starch we have 
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now carried out a similar experiment lasting 16 weeks. Dietary intake was 
strictly controlled during the whole period. 
This paper presents the results of lipoprotein lipid, apolipoprotein A,, 
and C T T/C T T T ratio analyses. 
SUBJECTS AND METHODS 
Subjects 
Twelve female and twenty-three male university students aged 19 to 30 
years participated in this study. The subjects were all unpaid volunteers. 
They were thoroughly informed about the nature of the experiment before they 
gave their informed consent. They were apparently healthy, as judged by a 
detailed questionnaire and had diastolic blood pressures below 90 mm Hg. 
Mean body weights per group were 68.4 ± 6.2 kg and 71.6 ± 11.2 kg for MOD 
and LO respectively; body fat percentages were 14 ± 4% and 13 ± 4% for males 
and 26 ± 4% and 26 - 3% for females in groups MOD and LO respectively. 
None of the volunteers had glucosuria or proteinuria. Two of the females 
used hormonal anticonception in each dietary group. 
Experimental design, diets and control of food intake 
The experiment lasted from 27th August until 14th December 1979. During the 
first 2.5 weeks of the study all subjects consumed a control diet (MOD) which 
was moderate in fat and high in PUFA (31% of daily energy as total fat, 11% of 
daily energy as PUFA) in agreement with the recommendations of The Netherlands 
Nutrition Council, the Dietary Goals for the US and other official recommenda-
tions. After this period the subjects were randomized into two subgroups strati-
fying for initial serum total and HDL cholesterol level, male/female ratio and 
energy intake. One group (MOD) continued on the moderate fat high-PUFA control 
diet, the other group (LO) received a low-fat test diet (21% of daily energy as 
total fat, 4% of daily energy as PUFA) for a period of 13 weeks (Fig. 1). 
Throughout the whole sixteen-week period all foodstuffs were weighed out 
for each person in quantities appropriate to his or her energy needs, except 
for 100 kcal/day, which the subjects were free to spend at will. Average energy 
intake during the control period was 10.1 MJ (2416 kcal) per day. 
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LO-diet: low-fat, low-PUFA (n = 17) 
MOD group [MOD-, iMOD-dietimoderate-fat, hiqh-PUFA(n=18) 
Fig. 1. Experimental design. 
Actual nutrient intakes were checked in all subjects by 7-day individual weighed 
records using Dutch food composition tables (6) to which analyses had been added 
of 5 special products (breads and margarines) used in this experiment and by 
analysis of double portions (7) for one imaginary person of average energy 
intake on each diet. 
Mean daily intakes of nutrients are given in Table 1. Analysis of double 
portions revealed a slightly higher absolute proportion of fat in the total 
daily energy intake in both groups, compared with computations from food tables 
but the differences between the two groups in fat intake, fatty acid composition 
and other nutrients agreed well with the food records. 
As an independent check on dietary fat consumption the fatty acid composi-
tion of cholesterol esters in serum was analysed (8, 9). The results are given 
in Table 2. During the test period the fatty acid composition in the control 
group MOD was unchanged while in the LO group the percentage of linoleic acid 
decreased markedly, with compensatory increases in monounsaturated and saturated 
fatty acids. 
Body weight was recorded weekly. Energy intake was adjusted when necessary 
in order to maintain body weight. The mean change per group in body weight over 
the 13 weeks of the test period was -1.4 ± 2.6 kg in group MOD and -1.7 ± 1.7 
kg in group LO. Three subjects in each group had lost between 3 and 7 kg. 
However, eliminating the data of these subjects from the analysis caused only 
negligeable changes in all parameters and did not affect the conclusions from 
the experiment. 
Urine was checked monthly for glucose and protein. Hemoglobin was measured 
monthly and was normal and stable in both groups during the experiment. 
Stools were collected during the first and the last seven days of the test 
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TABLE 1. MEAN DAILY INTAKE OF NUTRIENTS ACCORDING TO INDIVIDUAL FOOD RECORDSa) 
Habitual Controlc) Test periodd) 
intake period 
before 
experiment0"* (MOD) MOD LO 
Energy (MJ) 
(kcal) 
Protein (energy%) 
vegetable 
animal 
Total fat (energy%) 
total saturated 
C -C saturated 
monounsaturated 
ci-cis linoleic 
total polyunsaturated 
Carbohydrates (energy%) 
sugars 
starch 
Alcohol (energy^) 
Vitamin C (mg/day) 
Cholesterol (mg/1000 kcal) 
Phytosterols (mg/1000 kcal)e) 
Dietary fiber (g/1000 kcal) 
Polygalacturonic acid (g/1000 kcal) 
11.1 
2653 
13 
5 
7 
33 
15 
10 
12 
4 
5 
48 
23 
24 
6 
128 
112 
-
12.8 
1.2 
10.1 
2416 
15 
7 
8 
31 
8 
6 
10 
11 
11 
50 
20 
29 
1 
69 
108 
143 
15.9 
1.0 
10.1 
2470 
15 
7 
8 
31 
9 
6 
10 
10 
11 
50 
20 
29 
1 
86 
108 
153 
15.7 
0.9 
10.3 
2460 
16 
8 
8 
21 
7 
5 
8 
3 
4 
60 
20 
40 
1 
88 
106 
109 
18.6 
1.2 
a) 
The food records were elaborated using the Netherlands food composition 
tables supplemented with analysis of special breads and margarines. 
3-day records 
2-day records 
10-day records 
e) 
Measured by analysis of duplicate portions providing 2700 kcal/day. 
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period. There were no significant differences between groups in intestinal 
transit time (10), faecal output and moisture content or frequency of stools in 
either period. This confirms the conclusion that the difference in starch 
intake had not resulted in differences in dietary fibre consumption (see also 
Table 1). 
Blood sampling and analysis 
Blood samples were taken after an overnight fast before and during the 
experimental period at the intervals indicated in Fig. 1. 
No alcohol consumption was allowed for 24 h prior to blood sampling. Serum was 
obtained by low-speed centrifugation. 
Serum cholesterol was measured with Liebermann-Burchardt reagent (11) using 
serum calibrators calibrated according to Abel 1 et ai. (12). The lipid laborato-
ry was certified by the Center for Disease Control, Atlanta, G.A., USA, as 
meeting the WHO criteria. Reproducibility for blind control sera provided by 
the Center for Disease Control was 1.4% (coefficient of variation) and the 
absolute level (accuracy) was within 1.2% of the 'true' (target) values. 
HDL cholesterol was determined after manganese-heparin precipitation of 
apo-B containing lipoproteins (13) as previously described (14). For blind 
control sera obtained in the Center for Disease Control Survey of HDL-chole-
sterol Measurement (15) a reproducibility of 2.2% (coefficient of variation) 
was found. The bias with regard to the overall survey mean was on average 0.1%. 
VLDL was isolated for analysis of VLDL-apolipoprotein-CTT/C,T, ratios by 
selective precipitation with Mg-heparine according to (16) and apo-CTT/CTTT 
ratios were analysed by polyacrylamide slab gel electrophoresis in urea-
containing buffers (17). Protein bands were stained with Fast Green FCF and 
quantified by densitometer with 640 and 750 nm as sample and reference wave-
length respectively. 
Lipoproteins were fractionated by density gradient ultracentrifugation 
according to the procedure of Redgrave et al. (18) with several modifications 
as described previously (19) but without lipoprotein prestaining. 
Lipoprotein bands were harvested by tube slicing (d< 1.006 g/ml for VLDL, 
d = 1.006-1.070 for LDL, d = 1.070-1.125 for HDL2 and d> 1.125 for HDL . 
The upper density limit of LDL was increased slightly over the convential value 
of 1.063 so as to reduce contamination of HDL by sinking pre-beta lipoproteins. 
Cholesterol concentrations in ultracentrifuged fractions were determined 
enzymatically (CH0D-PAP kit, Boehringer) using serum calibrators as described 
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above. The mean recovery was 99% and the day-to-day variation coefficient for 
control sera 1%. Serum total, VLDL and LDL triglyceride concentrations were 
measured as described by Soloni (20). 
The changes in HDL cholesterol as measured after Mn-heparin precipitation were 
equal to the changes in cholesterol in total HDL as obtained by density gradient 
centrifugation. The percentual differences between HDL concentrations according 
to the two methods were 3.5%, 1.5% and 3.5% at the end of the control period, 
after 5 weeks of test period and after 12 weeks of test period respectively. 
The average correlation coefficient was 0.93. 
Apolipoprotein-B was measured in whole serum and in fresh ultracentrifugally 
isolated VLDL fractions by rocket Immunoelectrophoresis (21) as described (4). 
For apo-A, analysis, serum was first deli pi dated with redistilled tetramethyl-
urea and diluted with 8 M urea, 10 mM Tris-HCL, pH 8.2 (22). Apolipoprotein-Aj 
was then measured by rocket Immunoelectrophoresis as described (4) using rabbit 
anti-serum against apo-AT. The combined within-day and between-day coefficients 
of variation for control serum were 8.7% and 4.1% for the apo-B and the apo-A, 
assays, respectively. 
Statistical evaluation 
The multiple values obtained at the end of the control period and of the 
test period (Fig. 1) were averaged per person. The difference between these two 
averages, yielded the change over the test period. The mean of the changes in 
the L0 group was then compared with the mean of the changes in the MOD control 
group, using a 2-tailed Student's t-test. 
RESULTS 
Changes during the control period 
The time courses of serum total cholesterol, total triglyceride and HDL 
cholesterol concentration are given in Figs. 2, 3 and 4 respectively. Both 
groups received the moderate fat, high PUFA diet (MOD) during the first 2.5 
weeks of the study. During this control period average serum total cholesterol 
for all subjects combined decreased significantly by -0.68 ± 0.44 mmol/1 
(Fig. 2) of which on average only 0.02 ± 0.13 mmol/1 was located in HDL (Fig. 4). 
This was accompanied by a decrease of total serum apolipoprotein B of 
-131 ± 94 mg/1 and a decrease of total serum apolipoprotein A, of -131 ± 143 mg/1 
on average. 
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Effect of type and amount of fat on serum cholesterol levels 
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Fig. 2. Mean total serum cholesterol concentrations during the experiment and 
mean change in total serum cholesterol concentration during the test 
period. 0 # L 0 ; O O M 0 D (control). 
Vertical bars indicate 1 SEM; an asterisk denotes a significant 
difference (p< 0.05 or 0.01) between the changes in the control group 
MOD and the LO group. 
Total serum triglycerides decreased by 0.33 ± 0.41 mmol/l (Fig. 3). We did not 
stratify for total serum triglycerides which unfortunately resulted in a 
difference in absolute level between the groups. 
During the control period, the changes in those subjects who were later to 
consume the low fat diet were not significantly different from those in the 
subjects randomized into the control diet group. 
Changes during the test period 
During the test period total serum triglycerides (Fig. 3) did not change 
significantly in the control group HOD but increased by 0.31 ± 0.33 mmol/l in 
group LO (+61%) which was significantly different from the change in group MOD 
(p 0.05). Total serum cholesterol (Fig. 2) increased by +0.21 ± 0.41 mmol/l 
(+5%) in the control group HOD during the test period but remained stable in 
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the group which switched over to the low fat diet. 
Effect of amount and type of fat on serum triglycerides 
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Fig. 3. Mean total serum triglyceride concentrations during the experiment and 
mean change in total serum triglyceride concentrations during the test 
period.# # L 0 ; O O MOD (control). 
Vertical bars indicate 1 SEM; an asterisk denotes a significant differ-
ence (p<0.05 or 0.01) between the changes in the control group MOD and 
the LO group. 
Data for changes in lipoprotein concentration and composition during the 
test period are presented in Table 3. 
Changes in High Density Lipoproteins 
HDL cholesterol increased in the control group by +7% and decreased on the 
low fat diet by - « . The changes in HDL cholesterol in group MOD were mainly 
located in HDL2. In group LO HDL3 cholesterol had also changed, the change 
being smaller after 12 weeks than after 5 weeks. 
Apolipoprotein-A, concentrations were stable in both groups. The ratio of total 
HDL cholesterol to apo-Aj had increased in the control group by +5% after 12 
weeks and was unchanged in group L0, after an initial decrease of -3%. 
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Effect of type and amount of fat on HDL cholesterol 
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Fig. 4. Mean serum HDL-cholesterol concentrations (after Mn-heparin precipita-
tion) during the experiment and mean change in serum HDL-cholesterol 
concentrations during the test period.0 # L0;O O MOD 
(control). 
Vertical bars indicate 1 SEM; an asterisk denotes a significant 
difference (p<0.05 or 0.01) between the changes in the control group 
MOD and the LO group. 
Changes in Low Density Lipoproteins 
The concentration of LDL cholesterol remained rather stable in the group 
changing from the control to the low fat diet but increased slightly in the MOD 
control group. LDL triglyceride levels had not clearly changed. Changes in 
LDL-apo-B were minimal as were the changes in the ratio of LDL-cholesterol to 
apo-B. 
Changes in Very Low Density Lipoproteins 
After the transition from the moderate fat high PUFA control diet MOD to 
the low fat diet LO the mean concentration of cholesterol, triglycerides and 
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apolipoprotein-B in VLDL increased strongly compared with the group which 
continued on the control diet MOD. 
However, the effects did not reach statistical significance, because the 
standard deviations were also large. The ratio of apolipoprotein-C,T to C,., 
was unchanged until 5 weeks to test period but decreased slightly thereafter 
both in the LO group and in the MOD control group (-5.2 and -7% respectively). 
The ratio of triglycerides to apo-B in VLDL increased in both groups, indicating 
an increase in VLDL particle size on both diets. 
DISCUSSION 
The present experiment was set up to evaluate the effects of a low fat diet 
on lipoprotein concentration and composition as compared with a moderate fat, 
high PUFA diet on a more long-term basis then in our previous experiment (4). 
Thirty-five volunteers took part in the study, which lasted 16 weeks. 
Dietary intake was strictly controlled and independent checks on food intake 
(composition of cholesterolester fatty acids, intestinal transit time and fecal 
wet weight) confirmed dietary adherence. 
Effect of changing from the habitual diet to the high-PUFA control diet 
The habitual fat and cholesterol consumption in our group of participants 
(Table 1) is lower than the average intake in western countries, as described 
earlier (4, 7, 23). As a consequence the main difference between the habitual 
diet and the MOD diet of the control period was a higher P/S ratio of the 
latter. As might be expected (24, 25) this resulted in a decrease in serum 
cholesterol and triglyceride concentration. The decrease in serum cholesterol 
was even larger than predicted by the formulas of Keys and Hegsted, which was 
also the case in our previous experiment (4). 
As for individual lipoproteins, the decrease in serum cholesterol during the 
control period was located mainly in VLDL plus LDL; it was accompanied by a 
decrease in apo-B (footnote Table 3). 
HDL-cholesterol did not change during this period (fig. 4) but apolipoprotein-
A, concentrations fell markedly (footnote Table 3). 
This lack of an effect of dietary fat modification on HDL cholesterol concen-
trations in the control period cannot be ascribed to simultaneous changes in 
other factors which influence HDL levels: our subjects' level of exercise, body 
fatness, oral contraceptive use and cigarette smoking probably changed very 
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little upon entering the experiment, while their alcohol consumption decreased 
(Table 1), which only could have lowered HDL cholesterol levels. 
We have previously observed (4) that test diets that differed in P/S ratio but 
contained the same amount of fat and cholesterol caused differences in VLDL and 
LDL, but not in HDL cholesterol concentrations. 
Conventional lipid-lowering diets cause a decrease of HDL cholesterol (26, 27); 
we suggest that this is due not to the high P/S ratio but to the low total fat 
and cholesterol content of such diets. 
Changes during the test period 
Effect of the carbohydrate-rich diet on HDL 
The high-carbohydrate, low fat LO diet caused a clear-cut depression of 
HDL-cholesterol compared with the control MOD diet. The difference was due 
mainly to the cholesterol-rich HDL2 fraction. The latter was also reflected in 
the HDL cholesterol/apo A, ratio, which decreased. These results agree with 
observations of Blum et ai. (28), Schonfeld et ai. (29) and Levy et ai. (30), 
who report a lowering of HDL cholesterol in short-term controlled studies on 
high-carbohydrate diets containing less than 2% of energy as fat. Our results 
now suggest that these observations can be extrapolated to the normal range of 
fat consumption and to long-term intakes, because we find a permanent decrease 
of HDL cholesterol on lowering fat intake from 30 to 20% of energy. 
Epidemiological studies agree with this conclusion. Thus, Ernst et ai. (31) 
using data from the Lipid Research Clinics Program Prevalence Study, report a 
negative association between total carbohydrate, sucrose and starch intake and 
HDL cholesterol levels. We have recently reported (32) that among schoolboys 
from several countries low levels of total serum cholesterol were accompanied 
by low levels of HDL cholesterol and suggested that this might be due to a low 
consumption of fat-rich animal products, which would agree with the experimental 
results reported here. 
The difference in HDL cholesterol between the moderate- and low-fat diet 
(0.16 mmol/1 or 6 mg/dl) may seem modest, but it is in the same range as the 
difference between CHD victims and healthy controls (33) and it would predict a 
sizeable difference in coronary risk (34). 
As for the mechanism of the effect of fat intake on HDL, high density 
lipoproteins are intimately involved in fat catabolism, both as activators and 
as side products of the catabolism of fat-rich particles. The main protein 
component of HDL, apo-A,, is absent on nascent HDL particles emerging from the 
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liver. It is probably synthesized originally in intestinal cells as part of 
chylomicrons during fat absorption. As the chylomicrons are broken down they 
lose apo-A. and other surface materials, which are transferred to the HDL 
density range and are probably taken up by HDL3 under the formation of a less 
dense HDL2 like particle (35) through the action of the cholesterol-esterifying 
enzyme LCAT. On the other hand the chylomicrons obtain from HDL the apo-C,, 
protein which is essential for the breakdown of triglyceride-rich particles by 
lipoprotein lipase. Thus it should not come as a surprise that the healthy 
human organism will have a higher HDL-level when it has to handle higher daily 
fat loads and lower HDL-levels on low-fat diets. 
Variations in HDL cholesterol are often located in HDL . It was found, for 
example, that the higher level of HDL cholesterol in long-distance runners was 
mainly due to HDL~ (36). The higher level of HDL in females than in males was 
also found to be due to HDL2 (37). Blum et ai. (28) also found a relative 
decrease in HDL2 on a fat-free carbohydrate-rich diet. Thus it seems reasonable 
to expect that HDL2 is more sensitive to changes in diet than HDL as a whole. 
Effects of the carbohydrate-rich test-diet on total and LDL cholesterol 
Our previous experiment showed a slight increase in both total and LDL 
cholesterol and an increase in total serum apolipoprotein-B on the LO diet 
relative to the MOD diet, while the present study showed a decrease (Fig. 2 and 
Table 3). The difference with the previous experiment cannot be explained by 
dietary composition or dietary adherence (Tables 1 and 2), and we have to 
assume that it is due to chance fluctuations. Neither the change in total nor 
the change in LDL cholesterol differed significantly from the respective 
changes in the control group. 
In agreement with our previous experiment the ratio of LDL cholesterol to 
apolipoprotein-B showed only minimal changes. 
Carbohydrate-induced hypertriglyceridemia and VLDL 
In agreement with our previous experiment total serum triglyceride levels 
rose rapidly after the change-over from the control diet to the low fat, high 
carbohydrate diet and remained stable afterwards: there was no sign of a 
decrease of serum triglycerides up until 13 weeks on this diet. 
Several authors (38, 39) have reported that carbohydrate-induced hypertrigly-
ceridemia reaches a maximum within a few weeks and then starts to diminish 
again. However, none of these studies lasted long enough to establish whether 
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subjects' triglyceride values actually returned to baseline levels. 
An exception is formed by the experiment of Antonis and Bersohn (5). They 
reported that when fat intake was lowered from 40 energy^ to 15 energy^, tri-
glyceride concentrations increased and it took between 20 and 32 weeks for 
subjects' triglyceride values to return to baseline levels. Analysis of 
unpublished details of this study (Fig. 5) shows that the white prisoners who 
had initially received the high fat butter diet did indeed reach base trigly-
ceride levels. 
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Fig. 5. Influence on fasting serum triglyceride levels of reducing the 
proportion of fat calories in white South-African prisoners. 
| | , data for 12 subjects who had received the high-fat butter 
diet;Q Q , data for 13 subjects who had received the high-fat 
sunflower oil diet. No points are given beyond 25 weeks, because most 
subjects were removed from the study by then. (After unpublished data 
of Antonis & Bersohn; Kotze, J.P. personal communication). 
However, those who had started out on the high fat sunflower oil diet were 
still above their baseline triglyceride levels after 25 weeks on the high-
carbohydrate low-fat diet, when most of them were taken off the study. 
This suggests that total serum triglycerides on a low-fat diet will not return 
to baseline-level if the baseline control diet has been high in PUFA, in 
agreement with the findings reported here. 
Carlson and Ballantyne (40) (in contrast with Dewailly et ai. (41)) 
reported low levels of the apolipoprotein-Cjj/Cjjj ratio in the VLDL of hyper-
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triglyceridemic patients compared with controls, suggesting that changes in this 
ratio might play a role in the causation of hypertriglyceridemia. Schonfeld et 
ai. (29) found increases in apo-Cjr/Cjj, ratios after 5 days of high carbo-
hydrate liquid formula diets. In our experiment, however, we found no changes in 
apo-CTT/Crrj ratio on the low-fat diet as compared with the moderate-fat, high-
PUFA diet. Perhaps this is due to the small difference in carbohydrate content 
between our control and test diet, which was only 10 energyX carbohydrates as 
opposed to a difference of 40 energy0/ carbohydrates between free diet and test 
diet in the study of Schonfeld et ai. (29). 
Evaluation of the low-fat diet in comparison with the moderate-fat, high-PUFA 
diet 
Our data do not offer a definitive answer to the question which type of 
cholesterol-lowering diet should be preferred. Results for total serum or LDL-
cholesterol were equivocal, with the low-fat L0 diet causing higher LDL levels 
in our previous experiment (4) and lower LDL levels in the present experiment. 
Both types of diet are probably quite effective in lowering total serum chole-
sterol levels compared with what is found on habitual diets of affluent 
societies. There were, however, clear-cut differences in the effects on HDL and 
VLDL: HDL is depressed and fasting VLDL (and total serum triglycerides) are 
elevated by the low-fat high-carbohydrate L0 diet relative to the high-PUFA 
moderate-fat MOD diet. This is also reflected in the ratios of HDL to total 
cholesterol and of apolipoprotein-A, to apolipoprotein-B (Table 4 ) , which were 
both lowered by the L0 diet. 
The epidemiological and biochemical evidence suggests that high levels of 
HDL protect against coronary heart disease (33-35). However, there is as yet no 
evidence from controlled intervention trials that manipulation of HDL, be it by 
dietary or other means, will actually shift a person to another risk category. 
Thus, the importance of the effects described here with respect to athero-
genic risk remain to be established. 
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ABSTRACT 
The effect of different amounts and types of dietary fat on fecal steroid 
excretion in healthy volunteers was examined in the course of two controlled 
experiments. The first experiment lasted for 8 weeks and sixty volunteers took 
part in it. During a control period of 2.5 weeks all subjects received the 
control diet (MOD), containing 30% of daily energy as total fat, 11% of energy 
as polyunsaturated fatty acids (PUFA). Then four subgroups were formed. One 
group continued on the control diet, one group (L0) received 22% of energy as 
total fat, 3% as PUFA, one group (HIPUF) received 40% of energy as total fat, 
19% as PUFA and one group (HISAT) received 39% of energy as total fat, 3% as 
PUFA. Feces were collected during the last seven days of the control period and 
again during the last seven days of the test period, and analysed individually. 
In the second experiment with 35 volunteers, the low fat diet containing 21% of 
energy as total fat (4% as PUFA) was again compared with the control diet (31% 
as total fat, 11% as PUFA) but this time the test period lasted 13 weeks. 
Feces were collected during the first seven days of the test period and during 
7 consecutive days near the end of the test period and pooled per dietary group. 
Throughout the whole experimental period all foodstuffs were weighed out indivi-
dually and supplied according to each person's energy needs. Intake of chole-
sterol was approx. 250 mg per day; intake of dietary fiber was approx. 24 g per 
day in the first experiment and approx. 41 g per day in the second. Intake of 
cholesterol and dietary fiber was equal in all diet groups within each experiment. 
The latter was confirmed by measurement of fecal mass, percentage dry matter, 
mean transit time and frequency of stools, which showed no differences between 
the diet groups. 
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Fecal excretion of neutral steroids increased by 0.42, 0.30, 0.34 and 0.14 
mmol/24 h in the first experiment in groups L0, MOD, HIPUF and HISAT respective-
ly and by 0.12 and 0.23 mmol/24 h in the second experiment in groups LO and MOD 
respectively. (1 mmol of coprostanol = 389 rug). 
Bile acid excretion changed by +0.10, +0.01, +0.02 and -0.03 mmol/24 h in the 
first experiment in groups LO, MOD, HIPUF and HISAT respectively and by +0.18 
and -0.01 mmol/24 h in the second experiment in groups LO and MOD respectively. 
In neither experiment were the changes in the groups significantly different 
from each other. 
Neither the concentration of steroids in stools nor the degree of bacterial 
degradation was influenced by the diets. 
INTRODUCTION 
The effect of diet on fecal steroid excretion is of interest because of its 
possible relationship with changes in the level of serum cholesterol. In addi-
tion a relation has been suggested between intestinal steroids and colon cancer. 
Although the effects of dietary fat on serum cholesterol concentrations have 
been known for 25 years (1,2) the mode of action of the diet in changing serum 
cholesterol levels remains somewhat controversial. One of the proposed mechanisms 
is an increased excretion of fecal steroids, caused by decreased resorption of 
cholesterol or increased conversion of hepatic cholesterol into bile acids or 
both of these mechanisms. 
Dietary fat has been implicated in the etiology of cancer of the colon (3, 4) 
and it has been suggested (3, 5) that dietary fat acts by affecting the concen-
tration of certain steroids in the gut. 
Up until now conflicting results have been published on the effect of 
increasing the amount of dietary fat on fecal steroids. Increased excretion of 
fecal steroids was found by Antonis and Bersohn (6) and increased bile acid ex-
cretion by Cummings et ai. (7). However, a decrease of bile acid excretion on a 
high fat diet has also been reported (8). 
Replacement of saturated fatty acids by polyunsaturated fatty acids in the 
diet has been found to increase the fecal excretion of bile acids and neutral 
steroids (6, 9, 10). Others found that this effect was dependent on the amount 
of cholesterol (9, 11, 12) and the amount of plant sterols (13) in the diet. 
Replacement of carbohydrates by polyunsaturated fatty acids has also been 
found to increase fecal steroid excretion (6). 
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In the course of two controlled experiments on the effect of diet on serum 
lipoprotein concentration and composition we have re-examined the effect of 
different amounts and types of fat on fecal steroid excretion at constant 
cholesterol intake. Other results of these studies have been published else-
where (14-16). 
METHODS 
The design of the first experiment was as follows (Fig. 1). 
Control 
Time (weeks) 0 2 
Test Period 
10 12 14 16 
FIRST EXPERIMENT 
L0 group 
MOD group |M0D diet 
HIPUF group 
MOD diet L0 diet 
MOD diet 
n=16 
n=15 
MOD diet HIPUF diet n=15 
HISAT group [MOD diet | HISAT diet n=14 
Feces collection I I 
SECOND EXPERIMENT 
LO group 
MOD group 
MOD diet 
MOD diet 
Feces collection 
LO diet 
MOD diet 
17 
18 
Figure 1. Experimental design. 
LO = low fat, high carbohydrate diet. 22% of daily energy as fat, 
3% of daily energy as polyunsaturated fat. 
MOD = moderate fat, high polyunsaturated fat diet. 30% of daily 
energy as fat, 11% of daily energy as polyunsaturated fat. 
HIPUF = high fat, high polyunsaturated fat diet. 40% of daily energy 
as fat, 19% of daily energy as polyunsaturated fat. 
HISAT = high fat, low polyunsaturated fat diet. 39% of daily energy 
as fat, 3% of daily energy as polyunsaturated fat. 
Sixty young healthy student volunteers received a control diet for 2.5 weeks. 
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They were then randomized into four subgroups which received test diets as 
indicated in Fig. 1. The subgroups were stratified for initial serum cholesterol 
levels, male/female ratio and energy intake. The test period lasted 5 weeks. 
The second experiment with 35 volunteers differed from the first in that only 
two diets were tested, namely the low fat LO diet and the "Dietary Goals" diet 
MOD, and that the test period was extended to 13 weeks. 
In each experiment diets differed between groups in one component only; one 
group always received the control diet throughout the test period as a check 
against baseline drift. Throughout the whole experimental period all foodstuffs 
were weighed out individually and supplied according to each person's energy 
needs. Actual nutrient intake was measured by 7-day weighed food records using 
Dutch food composition tables (17) and by analysis of double portions (18) for 
one imaginary person of average energy intake on each diet. 
Diets 
The moderate fat control diet MOD in the first experiment contained 11% of 
total daily energy as polyunsaturated fatty acids (PUFA); in total, fat provided 
30% of daily energy (P/S 1.1). The low-fat, low PUFA diet LO provided 22% of 
energy as total fat (3% of daily energy as PUFA; P/S 0.4) the hiqh-fat, high PUFA 
diet HIPUF provided 40% of daily energy intake as total fat (19% of daily 
energy as PUFA; P/S 1.7) and the high fat, low PUFA HISAT diet provided 39% of 
daily energy as total fat (3% of daily energy as PUFA; P/S 0.2). In all diets 
protein provided 13% of daily energy and mono- and disaccharides 23%, while 
starch made up the total energy balance. Cholesterol intake was 244, 275, 255 
and 210 mg per day for groups L0, MOD, HIPUF and HISAT respectively. 
Intake of plant sterols was 247, 395, 530 and 270 mg per day and dietary fiber 
intake was 24, 24, 24 and 25 g per day for groups L0, MOD, HIPUF and HISAT 
respectively . 
In the second experiment the control diet MOD and the low fat, low PUFA diet 
L0 were tested again, but this time the test period lasted 13 weeks instead of 
5 weeks. Total fat intake and dietary fatty acid composition were equal to the 
first experiment. Cholesterol intake was 260 and 267 mg per day, dietary fiber 
intake was 46 and 39 g per day and intake of plant sterols was 269 and 384 mg 
per day for groups L0 and MOD respectively. 
In our earlier publication (14) the values for the plant sterol content of 
diets HIPUF and HISAT were accidentally interchanged. 
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Feces collection and analysis 
In the first experiment feces were collected during the last seven days of 
the control period and again during the last seven days of the test period, and 
analysed individually (Fig. 1). In the second experiment feces were collected 
during the first seven days of the test period and during 7 consecutive days 
near the end of the test period. In this experiment a fixed proportion of each 
subject's feces was pooled per dietary group and only pools were analyzed. The 
stools were usually frozen within 12 h of being passed and stored at -40°C. 
Mean transit time through the gut (MTT) was measured using radio-opaque markers 
(19). Fecal primary (cholic acid and chenodeoxycholic acid) and secondary 
(deoxycholic acid and lithocholic acid) bile acids were extracted and determined 
by gas-liquid chromatography according to Evrard (20). Cholesterol and the 
secondary neutral steroids (coprostanol, (epi)coprostanol and coprostanone) were 
measured according to Miettinen et ai. (21) but without prior thin-layer chroma-
tography. Repeated determinations on a control pool of freeze-dried feces 
revealed an inter-assay variability of 6.9% (coefficient of variation) for 
cholesterol and 6.5% for coprostanol and 5% for total bile acids. Fecal fat was 
measured in the first experiment as fatty acids after saponification (22). 
Statistical evaluation 
For statistical evaluation of results mean changes over the test period 
were compared between groups, using a two-tailed Student's t-test. For the 
second experiment, where only pooled samples were analyzed, standard deviations 
were estimated from previous experiments with comparable subjects (18, 23) and 
experiment 1. 
RESULTS 
Fecal mass and intestinal transit time 
Results for mass of feces passed per day, percentage dry matter, frequency 
of stools and mean transit time are given in Table 1. 
There were no differences between the groups in the changes over the test 
period, whether measured from end of control to end of test period (experiment 
1) or from start to end of test period (experiment 2). 
As reported previously (18, 23) there was a large variation in fecal output 
between subjects; in the control period, when all subjects consumed the same 
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diet, fecal wet weight, averaged over a seven-day period ranged from 28 to 246 
g per day and the percentage dry matter from 18 to 38%. Mean transit time 
through the gut ranged from 13 to 172 h. 
Fecal steroids and fat 
Fecal excretion of neutral and acidic steroids and of fecal fat is given in 
Table 2. There was an increase in the excretion of neutral steroids from the end 
of the control period to the end of the test period in all four groups in the 
first experiment. However, the changes in groups LO, HIPUF and HISAT were not 
significantly different from the change in the control group MOD. In the second 
experiment fecal excretion of neutral steroids increased from the first week to 
the end of the test period but again the change in group LO was not significant-
ly different from the change in group MOD, if we assume that the standard 
deviations in this experiment were comparable to those in previous experiments 
(18, 23) and experiment 1. 
Bile acid excretion (Table 2) was rather constant on all 4 diets in the 
first experiment. There was a slight increase on diet LO, a slight decrease on 
diet HISAT and no change on diets MOD and HIPUF. The changes in groups LO, HIPUF 
and HISAT were not significantly different from those in the control group MOD. 
In the second experiment fecal bile acid excretion was again unchanged on diet 
MOD, but on diet LO it was clearly higher at the end of the test period compared 
with the start of the test period. However, this change was not significantly 
different from the change in the control group MOD, again provided that we made 
the right estimations of the standard deviations. 
Fecal excretion of fat showed an increase in all four groups in the first 
experiment. The increase in the high-fat diet groups HIPUF and HISAT was signi-
ficantly greater than the change in the control group MOD. However, the differ-
ences were small in absolute terms. In the second experiment fecal fat was not 
measured. 
Changes in steroid and fat excretion related to changes in total serum chole-
sterol concentration 
In Table 3 the correlations between the changes in steroid excretion and the 
changes in total serum cholesterol concentration are given. 
If total serum cholesterol changes are related to changes in steroid excretion 
one would expect a negative correlation between the two: if serum cholesterol 
goes up, excretion should go down. This is not what we observed. Mean serum 
58 
a 
00 
LU 
31 
I— 
C3 
l—H 
Q : 
O 
I— 
<: 
Ll_ 
L-
O 
< 
CQ 
Q 
o 
a; 
o 
•z. 
o 
a: 
LU o 
s: S-
>—i C7> 
a; 
UJ +-> 
a . ai 
X T -
LU Q 
• - . " 
I-; " 
l— a. 
LLJ O 
S i -
»—i Kyi 
a: 
uu +J 
a. a) 
X •!-
LU O § : 
LO 
O r-l 
- J II 
O 
LO 
i-H i - l O 
LO CM 
«=|- r-H 
+ 
<a-
CM 
1 — 
o 
E 
E 
LO 
o 
+ 1 
L O 
CO 
1—1 
L O 
* 3 " 
o 
+ 1 
0 0 
t — 1 
I - H 
LO 
o 
+ 1 
L O 
«—1 
LO 
o 
+1 
CM 
^ 1 -
T — * 
• a 
1 3 
T3 
T3 
o 
+ 1 
o 
LO 
t — 1 
CO 
o 
+ 1 
CM 
CO 
r—1 
LO 
o 
+ 1 
LO 
en 
T — 1 
O 
LO 
O 
+ 1 
1 -
co 
i—» 
CTl 
CO 
O 
+ 1 
«3-
t—1 
O 
+ 
LO 
o 
+ 1 
co 
o 
+ 
o 
+ i 
o 
ro 
O 
+ 
o 
+ 1 
CM 
•a-
o 
oo 
. - i oo 
CTl r-1 
o 
+ 
CO * - N 
CM X> 
O 
+ 1 
1 ^ 
L O 
o 
L O 
CM 
O 
+1 
o 
CTl 
r - H 
o 
+1 
CO 
o 
o 
L O ^ 
CO X 
O 
+ 1 
LO 
o 
LO / ~ s 
CO X 
o 
+ 1 
o 
*3-
co 
o 
+1 
r-. 
o 
o 
CO 
o 
+1 
o 
LO 
r-4 
O 
+1 
CM 
O 
O 
+ 
LO 
o 
+1 
r - H 
O 
O 
+ 
CM ^ 
CO X 
O 
+ 1 
LO 
o 
CTl 
CM 
O 
+1 
i - ^ 
o 
T - H 
CM 
O 
+1 
O 
r—f 
o 
+ 
CM 
LO 
4-> 
<D 
• i — 
• a 
Q 
o 
s : 
— 
-a 
o 
•r— 
S-
cu 
Q . 
i — 
o 
i -
+-> 
c 
o 
O 
-a 
o 
• i — 
S-
O) 
a . 
+-> 
L0 
CD 
+-> 
• * -> 
S-
ro 
4-> 
0 0 
X I 
O 
• r— 
S-
<D 
D . 
+-> (/) CD 
•4-> 
X I 
C 
U J 
-a 
o 
s-
a> 
O -
+-> 
t / i 
a> 
+-> 
S-
CD 
> o 
O) 
O l 
c 
CO 
. c 
o 
LO 
X I 
• i — 
o 
oo 
<D 
i — 
•r— 
CQ 
+ J 
(LI 
• i -
X I 
Q 
O 
s : 
% 
-o 
o 
• 1 — 
s-
<u 
D . 
1 — 
o 
s-
+ J 
C 
o 
o 
X J 
o 
c ai a . 
4-> 
Ul 
a i 
-r-> 
+ J 
s_ 
ia 
•(-> oo 
-a 
o 
•r— 
i . 
ai 
Q . 
4-> 
t n 
11 
• ! - > 
X I 
c 
U J 
X i 
o 
si 
ai 
a . 
4-> 
t / ) 
ai 
+ J 
s-
cu 
> o 
CD 
CD 
C 
IO 
J = 
t_> 
L0 
X I 
• r— 
o 
IO 
> 1 
+-> 
+-> ( 0 
u. 
4-> 
CD 
• I — 
X I 
Q 
O 
s : 
« — • 
X J 
o 
• 1 — 
s-
a i 
a . 
r— 
o 
s-
+ J 
c 
o 
o 
X I 
o 
• 1 — 
s-
OJ 
Q . 
• P 
i -
10 
•(-> 0 0 
X I 
o 
• I— 
S-
cu 
a . 
+ J 
t/> 
cu 
+-> 
X ) 
c 
L U 
X J 
o 
s-
cu 
a . 
• ! - > 
L0 
cu 
+ J 
s-
CD 
> o 
CU 
en 
c 
10 
J = 
L J 
oo xi 
t - H 
+1 
0 0 
• e f 
CO 
CO 
+1 
CM 
r--
CM 
+1 
<* 
CM 
co 
1 T—i 
1 +1 
1 CO 
1 1 — 
r—1 
+1 
CM 
r - H 
+ 
LO CO 
U3 O 
• * Xi 
CM 
+1 
0 0 
CM 
+1 
CO 
CM 
+1 
o 
+ 
59 
6 0 
B 
ro 
CO 
" . CM 
6 0 
e ii 
ON / - s 
00 - 0 
r o -H 
CJ 
II n) 
, - s o 
i- l -H 
o cu 
C •"-! 
co o 
4-» 
t o CO 
o rt 
M <~-
p . 
O CO 
o -a 
•r-4 
CO c j 
nt co 
>—' 
>> CO 4-1 
T3 4-J 
• r-i to 
O U-l 
n 
ai m 
4-1 0 
CO 
r—1 
t -1 O 
m g 
S-J E 
4-1 
3 — CU 
c • « 
6 0 
M-I B 
o 
c o 
i—1 O N 
O c-0 
g 
B II 
— ^^  T 3 
• • - H 
CO CJ 
4-1 co 
• H 
3 o 3 -H 
r-1 
I - I o 
cd , 3 
3 cj 
o >> 
•H X 
4J O 
• H <D 
X I T 3 
CO 
1-4 CO 
4J CO 
^^  O 
4-1 CO 
T3 
r-4 -r-1 
c o c j 
CO 
B 
o cu 
1-4 t - l 
M-t -r-t 
J 3 
c 
O CH 
• H O 
CO 
H 1-4 
CU o 
> i C B 
0 
o — 
CO 
cu 
CJ 
cu 
4-1 
•a 
cu 
CO 
>> r-4 
CO 
s CO 
>. r-4 
r - t 
CO 
3 
T 3 
• r4 
r> 
• H 
T3 
3 
• H 
CM 
O 
CO 
4J 
i—1 
3 
CO 
cu 
OS 
• T J 
CU 
1-4 
3 
CO 
CO 
CU 
B 
4-1 
o 
s 
•a 
o 
• H 
u 
a i 
D , 
4J 
CO 
CU 
4-1 
4J 
1-1 
CO 
4J 
CO 
• CO 
A: 
cu 
OJ 
3 
u-l 
•a 
o 
-r-i 
u CU 
p . 
4J 
CO 
CU 
H 
T 3 
CU 
4J 
CO 
S 
•H 
4J 
CO 
w 
• CO 
CU 
CJ 
CU 
CM 
- 0 
OJ 
r—4 
0 
0 
1-1 
0 
4-1 
JS 
• » 
CN 
r-1 
0 
g 
ON 
m 
• o 
T> 
3 
CO 
CO 
o. -a 
«-, 0 
CO 
• H 
CO 
• H 
CJ 
CO 
CU 
I—1 
• 1-1 
>% , Q 
r-4 
CO 
C 
CO 
4-1 
0 
CO 
4J 
r—1 
3 
CO 
CU 
PS 
T 3 
OJ 
V4 
3 
CO 
CO 
OJ 
E 
4J 
0 
s 
1 3 
O 
• H 
U 
CU 
1-1 
o 
M-I 
X: 
<r 
CN 
-— T — 1 
o 
£ 
r o 
CO 
O 
• • ^ s
~ 
4 J 
3 
CU 
B 
• H 
1-1 
CU 
p . 
X 
cu 
a -a 
r—1 
o 
>-l 
4J 
c 
o 
o 
CO 
AS 
cu 
cu 
s 
CN 
— 
T 3 
o 
• H 
Sj 
cu 
p . 
4J 
CO 
cu 
H 
c 
cO 
CO 
CN 
* 0 0 
— 
-—' 
CO 
c 
o 
• H 
4-1 
CO 
• H 
> CU 
•a 
T 3 
1-1 
CO 
T 3 
s CO 
4J 
CO 
CO 
T 3 
• H 
o 
1-1 
cu 
4-1 
CO 
T-l 
CO 
U 
4J 
3 
CU 
3 
-0 
s CO 
CO 
T 3 
• H 
CJ 
CO 
CU 
r-1 
•r4 
J 3 
1-1 
o U-l 
. 3 
<t 
CN 
-— r—1 
O 
g g 
r o 
CN 
• O 
T3 
O 
• H 
1-1 
CU 
P. 
4-1 
CO 
CU 
4J 
S-4 
CU 
> 
o 
CU 
6 0 
3 
co 
,c 
CJ 
1-1 
o 
4-1 
CO 
3 
o 
• H 
4 J 
cO 
• r4 
> CU 
T3 
• a 
i-i 
CO 
" d 
3 
cO 
4J 
CO 
•a 
cu 
4-1 
CO 
B 
• H 
4J 
CO 
w 
• CO 
-a 
•r-i 
o 
u CU 
4-1 
CO 
r-^ 
CO 
H 
4-1 
3 
CU 
C 
l-i 
O 
y- i 
X 
<r 
CN 
—^ r-1 
o g g 
o 
vO 
o 
• o 
CU 
u 
a CO 
CO 
CU 
B 
4J 
o 
a 
• 
4J 
CO 
CU 
4J 
1 
4J 
* 
—-o 
• o 
V 
o. 
o 
o g 
p . 
3 
o 
1-1 
6 0 
t—1 
o 
1-1 
4J 
3 
o CJ 
3 
• H 
CU 
6 0 
C 
CO 
.e CJ 
B 
o i-i 
CW 
4J 
3 
CU 
1-4 
CU 
CW 
CW 
• H 
• a 
>^  i—i 
4-1 
3 
cO 
CJ 
• H 
C4-1 
• H 
C 
6 0 
• r - 1 
CO 
-a 
o 
• H 
V4 
CU 
P. 
4J 
CO 
CU 
4-1 
1-1 
CU 
> o 
cu 
6 0 
3 
CO 
.e 
o 
60 
o 
DC 
o 
DC 
_ 1 a) 
O • - ! 
DC 1-1 
LU DC 
in LU 
< 3= 
o 
LU 
TH. 
m 
a. 
ra 
o DC 
o 
LU O 
3 
I— LU 
LU nr 
OQ I— 
S- 1—i 
J — 4 
(_> 1 1 
LL. 
U . 
LU 
O 
C_) 
z: 
o CO 
DC 
LU 
D_ 
cc 
I— o 
< : i - i 
_ l h -
LU LU 
DC DC 
DC O 
O X 
o 
s-
Q 
O 
s: 
o 
_ j 
•r- - i— 
M- S-
M- 0) 
<D Q . 
O 
O 4-> 
to 
C O) 
o +-> 
+J Ol 
fO - C 
1— +-> 
Q) 
! - i -
S- (U 
O > 
o o 
0 0 r~-
• - I o 
43 
LO *d" 
cvj * i -
o 
o 
c 
o 
•;-
a; 
i -
o X 
CD 
U 
X 
CD 
-a 
• i — 
o i-
<D 
o 
o 
nj 
T3 
r H 
nt 3 
13 
• ^  > • H 
•a 
a 
• H 
0 
E5 
•H 
X) 
>, r H 
4-J 
a 
nf 
o 
• H 
I H 
•r-l 
c 00 
•H 
en 
61 
cholesterol concentrations remained stable in groups MOD and HIPUF and in-
creased in groups LO and HISAT, by 0.25 and 0.38 mmol/1 respectively (14). 
However, as shown in Table 2, group means of fecal neutral steroid excretion 
increased in all four groups and bile acid excretion was almost unchanged. 
Within each diet group, different individuals reacted differently to the diet. 
As shown in Table 3 there was a negative correlation between a subject's change 
in serum cholesterol and his or her change in excretion of bile acids within 
group LO. In general, however, the correlation between individual changes in 
serum cholesterol level and fecal steroid excretion within a group was weak and 
inconsistent. 
Fecal concentration of steroids and percentage secondary steroids 
The fecal concentration of neutral steroids at the end of the control period 
in the first experiment was 15 mmol per kg wet feces; the fecal concentration 
of bile acids was 7 mmol per kg wet feces. The fecal concentration of neutral 
steroids and bile acids at the start of the test period in the second experiment 
was 10 mmol and 6 mmol per kg wet feces respectively. The changes in fecal 
steroid concentration were small in both experiments and there were no statistic-
ally significant differences between the diet groups. 
At the end of the control period of the first experiment, 91% of the neutral 
steroids and 73% of the bile acids in the feces consisted of secondary steroids, 
formed from primary steroids by bacterial activity. Changes over the test period in 
the proportion of secondary products on the various test diets ranged on average 
from -2 to +4 percentage points for neutral steroids and from -8 to +5 percent-
age points for bile acids. The changes were not significantly different from 
changes in the control group MOD. 
The results for the second experiment were similar. 
DISCUSSION 
The present experiments were set up to evaluate the effects of type and 
amount of dietary fat on serum lipoprotein composition and concentration. 
One of the possible mechanisms by which dietary fat influences serum cholesterol 
concentration is by increasing the excretion of fecal steroids. However, we 
found neither an acute nor a chronic effect of type and amount of dietary fat on 
fecal excretion of neutral steroids and bile acids in two carefully controlled 
experiments with large groups of participants and using natural foodstuffs. 
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Replacement of saturated by polyunsaturated fatty acids 
In the first experiment we found no difference in excretion of bile acids 
and neutral steroids in the feces between subjects on diets HIPUF and HISAT. 
These diets contained the same amount of fat and cholesterol, but had P/S ratios 
of 1.7 and 0.2 respectively. 
Table 4, part I, lists studies on the effect on fecal steroid excretion of 
replacing saturated by polyunsaturated fat. Only controlled studies with healthy 
subjects consuming natural solid diets are included. Evaluation of research on 
the effect of diet on fecal steroid excretion is hampered by the great differ-
ences in experimental design, type of diet and type of participants between the 
various studies. Therefore, studies with liquid formula diets were excluded 
because they usually have a very low fiber content, which could interfere with 
the results. Studies of patients with disorders of lipid metabolism were also 
excluded because such patients are known to have a fecal steroid excretion 
different from healthy controls (24). The intake of cholesterol and plant 
sterols are given because these components influence fecal steroid excretion 
(11-13). 
As can be seen from Table 4, replacement of saturated by polyunsaturated 
fatty acids led to increased bile acid excretion in the experiment of Antonis 
and Bersohn (6). Although sterol consumption was not listed, the intake of 
cholesterol was probably lower and the intake of plant sterols higher on the 
polyunsaturated diet. Moore et ai. (10) found modest increases in bile acid 
excretion on a high safflower oil diet compared with a butter diet, but the 
intake of cholesterol and plant sterols was not constant; Nestel et ai. found 
no effect of polyunsaturated fatty acids in one experiment (9) and in another 
experiment they found an increase in bile acid excretion only when the chole-
sterol content of the diets was high (11). 
Replacement of saturated fat by polyunsaturated fat led to a higher excre-
tion of neutral steroids in the above-mentioned experiments, although it cannot 
be excluded that the analysis of fecal neutral steroids in the experiment of 
Antonis and Bersohn included some plant sterols. Eneroth et ai. (25) also found 
modest increases in fecal neutral steroid excretion on a high corn oil diet 
compared with a butter diet. One might speculate that this was at least partly 
due to the higher intake of plant sterols on diets rich in polyunsaturated fat. 
However, in our experiment we did not find a higher excretion of neutral 
steroids on diet HIPUF than on diet HISAT, despite a higher intake of plant 
sterols on diet HIPUF. 
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In our first experiment the intake of cholesterol was almost identical in 
all four groups, and uniformly low. According to the study of Nestel et ai. (11) 
this might have obscured an effect on bile acid excretion. However, it is not 
likely that this also explains the absence of a difference in neutral steroid 
excretion between diets HIPUF and HISAT. 
Replacement of carbohydrates by fat 
Studies on the effect of the proportion of fat in the diet on steroid excre-
tion are rare. The few controlled studies with healthy subjects and regular 
diets that we are aware of are listed in the second part of table 4. Replacement 
of carbohydrates by butter led to a decrease of bile acid excretion and a small 
increase in neutral steroid excretion in the experiment of Antonis and Bersohn. 
Surprisingly, in another phase of the same experiment replacement of butter by 
carbohydrates gave the same results. Cummings et ai. found an increase in bile 
acid excretion when the proportion of saturated fat in the diet was increased. 
However, the intake of cholesterol was also increased. 
Antonis and Bersohn found increased bile acid and neutral steroid excretions 
when carbohydrates were replaced by polyunsaturated fat, while the reverse was 
found when polyunsaturated fat was replaced by carbohydrates. In our experiment 
we found no differences in fecal steroid excretion on diets with different 
amounts of polyunsaturated fat. 
It has been suggested that the transition to a diet high in polyunsaturated fat 
causes a temporary increase in fecal steroid excretion which subsides when 
steroid metabolism in the body has reached a new equilibrium. However, in 
experiment 2 we saw no significant difference between the excretion on the low 
fat LO diet in the first and in the thirteenth week after the change of diet. 
It would appear logical that an increase of fat in the diet leads to the 
excretion of more bile acids in the gut. However, the effect on total excretion 
has not been shown convincingly. The relation between changes in fecal steroid 
excretion and changes in serum cholesterol concentration within one diet group 
was also weak in our experiments. 
Thus, differences at the intestinal level apparently do not explain the 
different ways in which serum cholesterol levels of individuals reacted to a 
given diet. 
Fecal steroid concentration and composition 
Populations consuming low-fat diets were reported to have lower concentra-
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TABLE 4. DAILY FECAL STEROID EXCRETION IN SUBJECTS ON DIETS WITH DIFFERENT AMOUNTS OR TYPES OF FAT OR BOTH. 
DATA ARE GIVEN ONLY FOR CONTROLLED STUDIES OF SUBJECTS WITH NORMAL LIPID METABOLISM CONSUMING 
NATURAL SOLID DIETS. 
Diet Fecal excretion 
Authors 
Part I. Studies on 
Antonis and 
Bersohn (6) 
Eneroth et al.(25) 
Moore et al. (10) 
Nestel et ai. (9) 
Number 
partici 
the typ 
9 
6 
8 
5 
6 
6 
5 
5 
5 
5 
of 
par ts 
e of d 
Duration 
ietary fat 
29 
8 
29 
8 
4 
4 
16 
16 
4 
4 
weeks 
weeks 
weeks 
weeks 
weeks 
weeks 
days 
days 
weeks 
weeks 
Amount of 
fat (% of 
energy) 
40 
40 
40 
40 
40-50 
40-50 
40 
40 
45-50 
45-50 
Type of fat 
butter 
sunflower 
seed oil 
sunflower 
seed oil 
butter 
butter 
corn oil 
butter 
safflower oil 
ruminant 
saturated 
ruminant poly-
Chole-
sterol 
(mg/day) 
a) 
a) 
a) 
a) 
271 
141 
347 
197 
i500 
±500 
Plant 
sterols 
(mg/day) 
a) 
a) 
a) 
a) 
0 
447 
420 
720 
a) 
a) 
Bile acids 
(mg/day) 
286 
524 
640 
427 
a) 
a) 
473 
564 
196 
271 
Neutral 
steroids 
(mg/day) 
169 
399 
463 
261 
527 
614 
486 
580 
607 
681 
unsaturated 
Nestel et al. 
Nestel et al. 
(11) 
(12) 
5 
5 
5 
5 
3 
3 
19 
23 
23 
23 
28 
28 
days 
days 
days 
days 
days 
days 
42-44 
42-44 
42-44 
42-44 
44 
44 
Dairy fat, 
beef, lamb 
high choleste-
rol, saturated 
high chole-
sterol , poly-
unsaturated 
low choleste-
rol , saturated 
low chole-
sterol , poly-
unsaturated 
pork saturated 
pork poly-
unsaturated 
789 
796 
493 
520 
549 
535 
a) 
a) 
a) 
a) 
a) 
a) 
281 
381 
297 
314 
231 
239 
806 
1039 
674 
847 
830 
1096 
Data not given 
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TABLE 4. Continued 
Diet 
Authors Number of Duration Amount of Type of fat 
participants fat (% of 
energy) 
Fecal excretion 
Chole- Plant Bile acids Neutral 
sterol sterols steroids 
(mg/day) (mg/day) (mg/day) (mg/day) 
Part II. Studies on the amount of fat. 
Antonis and 
Bersohn (6) 
Whyte et al. (8) 
Cummings et al. 
(7) 
39 weeks 
22 weeks 
8 weeks 
17 weeks 
39 weeks 
22 weeks 
8 weeks 
17 weeks 
2 weeks 
2 weeks 
2 weeks 
2 weeks 
2 weeks 
2 weeks 
4 weeks 
4 weeks 
15 
40 
40 
15 
15 
40 
40 
15 
68 
10 
69 
5 
10 
68 
21 
48 
prison diet 
butter 
butter 
prison diet 
prison diet 
sunflower 
seed oil 
sunflower 
seed oil 
prison diet 
safflower 
oil 
high sucrose 
diet 
safflower 
oil 
high sucrose 
diet 
high sucrose 
diet 
saturated 
fat (lard) 
saturated 
fat 
saturated 
fat 
513 
502 
219 
233 
652 
652 
466 
732 
a) 
a) 
a) 
a) 
a) 
a) 
a) 
a) 
423 
383 
375 
20 
20 
al 
a) 
a) 
a) 
a) 
a) 
a) 
a) 
a) 
a) 
a) 
450 
353 
427 
351 
539 
577 
524 
321 
397 
513 
266 
301 
425 
238 
140 
320 
184 
294 
261 
379 
223 
636 
399 
270 
859 
848 
555 
336 
690 
761 
a) 
a) 
Data not given 
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tions of steroids in their feces than affluent populations (3, 26). This is 
explained most easily by assuming that these low-fat diets have a high content 
of cereal fiber. This is known to increase fecal bulk, thus diluting the steroid 
concentration. In our experiment fiber intake was kept constant over the whole 
range of fat intatce; as a result, intestinal transit time, fecal mass and fecal 
steroid concentration also remained constant. 
Populations consuming different diets have been found to differ in the 
extent of bacterial degradation of their fecal steroids (27). However, in 
controlled experiments consistent effects of diet on the ratio of primary to 
secondary bile acids or neutral steroids have not been observed (28). This 
agrees with our own results. It could be that much longer periods are necessary 
to establish a new equilibrium in the gut, or alternatively, that the differ-
ences observed between different groups of people are caused by differences 
other than their dietary habits. 
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ABSTRACT 
The effects of type and amount of dietary fat on fasting and postprandial 
plasma glucose and insulin were investigated. In the first experiment 60 young 
healthy volunteers received a moderate fat control diet rich in polyunsaturated 
fat (30% of daily energy as total fat, 11% as polyunsaturated fat) for a 
control period of 2| week, after which they were randomized into 4 subgroups 
for a test period of 5 weeks. One group continued on the control diet. Three 
other diets were investigated: one low in total fat and low in polyunsaturated 
fat (21% of daily energy as total fat, 3% as polyunsaturated fat); one high in 
total fat and low in polyunsaturated fat (39% of daily energy as total fat, 3% 
as polyunsaturated fat) and one high in total fat and high in polyunsaturated 
fat (40% of daily energy as total fat, 19% as polyunsaturated fat). In the 
second experiment the moderate fat, high polyunsaturated fat diet and the low 
fat, low polyunsaturated fat diet were compared again, but this time the test 
period lasted 13 weeks. Serum insulin and plasma glucose levels were measured 
in fasting blood and one hour after the beginning of a test meal, the composi-
tion of which was similar to that of the respective diet as a whole. We found 
no effect of type or amount of dietary fat on fasting plasma glucose and 
insulin levels nor on the postprandial rise in plasma glucose and insulin. 
INTRODUCTION 
Diabetes and hypercholesterolemia are both risk factors for cardiovascular 
disease. The effect of various cholesterol-lowering diets on carbohydrate 
metabolism are thus of interest, because a diet that is optimal for serum 
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cholesterol concentrations does not necessarily improve the handling of glucose. 
As far as dietary fat is concerned, two types of dietary changes have been 
advocated for the prevention and/or treatment of hypercholesterolemia, namely 
replacement of saturated by polyunsaturated fatty acids and reduction of total 
fat intake, accompanied by an increase in carbohydrate consumption. Favorable 
effects on glucose tolerance have been described for both high-carbohydrate 
diets (1-3) and for high linoleic acid diets (4). However, long-term controlled 
studies of the effects of such diets on plasma glucose and insulin levels in 
healthy subjects are quite rare, and the diets tested have often been artificial 
and not composed of regularly used foodstuffs. 
We have recently completed two studies on the effect on cardiovascular risk 
factors of a high-starch, low-fat diet compared with diets higher in fat and 
having various degrees of polyunsaturate. Data on the effects of these diets 
on composition and concentration of serum lipoproteins (5, 6) and on blood 
pressure (7) have been reported. This report deals with effects on plasma 
glucose and insulin levels, both fasting and after a test meal of the same 
composition as the diet under study. 
METHODS 
Subjects 
The subjects were all unpaid volunteers, aged 18-30 years. They were 
apparently healthy as judged by a detailed questionnaire and had diastolic 
blood pressures below 90 mm Hg. None of the volunteers in the seond experiment 
had glucosuria or proteinuria; in the first experiment this was not measured. 
Two of the females in the first experiment and four in the second experiment 
used hormonal anticonception. 
Mean body weights were 71.1 kg for males and 59.6 kg for females in the 
first experiment and 73.8 kg and 62.7 kg respectively, in the second experiment. 
Mean body fat percentage (8, 9) for males was 13% and 14% and for females 27% 
and 26% in the first and second experiment respectively. Body fat percentage 
never exceeded 23% for males and 30% for females. 
The average fasting serum triglyceride concentration at the start of the 
experiments was 0.69 ± 0.44 (range: 0.14 - 2.18) and 0.96 ± 0.43 (range: 0.35 -
2.32) mmol/1 and fasting serum cholesterol was 4.25 ± 0.72 (range: 2.95 - 5.82) 
and 4.60 + 0.75 (range: 3.50 - 6.33) mmol/1 for participants in the first and 
second experiment respectively. 
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The habitual diet of our participants contained on average 33% of daily 
energy as total fat, 5% of daily energy as polyunsaturated fat, 13% as protein, 
40% as total carbohydrates and 24% of daily energy as oligosaccharides. Alcohol 
yielded 5% of daily energy on average. 
Their habitual cholesterol intake was low (290 mg per day) and the intake of 
dietary fiber high (39 g per day). 
Experimental design 
Experiment I was carried out from October 9 till December 1, 1978 and 
experiment II from August 27 till December 14, 1979. 
During the first 2.5 week of the first experiment 60 young, healthy volunteers 
(37 men and 23 women) received a moderate fat control diet, rich in poly-
unsaturated fatty acids (PUFA) (30% of daily energy as total fat, 11% of daily 
energy as PUFA) in agreement with the recommendations of the Netherlands 
Nutrition Council, the Dietary Goals for the US and other official recommenda-
tions. They were then randomized into 4 subgroups, which received test diets 
for the next five weeks as indicated in Fig. 1. The subgroups were stratified 
for initial serum cholesterol level, male/female ratio and energy intake. 
In the second experiment 35 volunteers (23 men and 12 women) took part. The 
design differed from the first in that the test period was prolonged to 13 
weeks and only two diets were tested, namely the low fat L0 diet and the 
"recommended" diet MOD. 
In each experiment diets differed between groups in one component only; one 
group always received the "recommended" control diet throughout the test period 
as a check against baseline drift. Throughout the whole experimental period all 
foodstuffs were weighed out individually and supplied according to each person's 
energy needs. Actual nutrient intake was measured by 7-day weighed food records 
using Dutch food composition tables (10) and by analysis of double portions (11) 
for one imaginary person of average energy intake on each diet. 
The detailed composition of the diet is given in Table 1. In both experiments 
feces were collected for two 7-day periods. Intestinal transit time, fecal wet 
and dry weight and frequency of stools were equal between diet groups. This 
confirms the absence of physiologically significant differences in dietary fibre 
intake. 
Blood sampling and analysis 
Blood samples for insulin and glucose measurements were collected before 
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Time (weeks) 
Blood sampling 
Control 
0 2 
1 1 
Test Period 
4 6 8 
P 1 1 
10 
I 
12 
I 
U 
I 
16 
I 
FIRST 
/t5iet 
Meals 
Time 
Blood 
sampli 
MOD 
M 
Test ^ ~ \ 
IS 
8^ 00 1200 16!00 
ngt t 
EXPERIMENT 
LO group 
MOD group 
HIPUF group 
HI SAT group 
|MODdiet|LOdiet 
|M0Ddiet|M0D diet 
|M0D diet [HIPUF diet 
|MODdiet |HISAT diet 
o'clock 
n = 16| 
n = 15| 
n=15| 
n=u| 
SECOND EXPERIMENT 
L0 group 
MOD group 
|MODdiet| 
|MODdiet| 
LO diet 
MOD diet 
n = 17 | 
n = 18 | 
Figure 1. Experimental design. The inset shows the blood sampling scheme on 
the first day of the test period. 
LO = low fat, high carbohydrate diet (22% of daily energy as fat, 
3% of daily energy as polyunsaturated fatty acids). 
MOD = moderate fat, high polyunsaturated fat diet (30% of daily 
energy as fat, 11% of daily energy as polyunsaturated fatty 
acids). 
HIPUF = high fat, high polyunsaturated fat diet (40% of daily 
energy as fat, 19% of daily energy as polyunsaturated fatty 
acids). 
HISAT = high fat, low polyunsaturated fat diet (39% of daily energy 
as fat, 3% of daily energy as polyunsaturated fatty acids). 
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breakfast at the end of the control period and again one hour after the 
beginning of a test-lunch on the same day (Fig. 1). Breakfast on this day was 
the last meal of the control period and was still the same for all participants; 
the test-lunch constituted the subjects' first exposure to the various test 
diets. Blood samples were collected again after 5 weeks of test period in both 
experiments and for a third time after 13 weeks of test period in the second 
experiment. On each occasion, blood was sampled before breakfast and one hour 
after the subject had started to eat lunch. On these days the composition of 
both breakfast and test lunch corresponded to the test diet to which the 
subject had been assigned and both breakfast and test lunch were thus different 
for each diet group. Subjects were asked to refrain from smoking from the 
moment they rose until the postprandial blood sample had been collected. 
The lunch consisted of cooked vegetables, potatoes, gravy, a salad with egg 
and dessert and contained 25% of the day's calories. The lunch was weighed out 
and its composition recorded for each subject. 
Blood for glucose analysis was collected into evacuated tubes containing 
0.2 mg NaF and 1.0 mg dipotassium EDTA per ml blood, and stored in ice. Plasma 
glucose was measured by the ferricyanide method of Hoffman (12) within 24 hours 
after blood sampling. Reproducibility for blind controls was 2.6% (coefficient 
of variation). 
Insulin was measured in serum by radio-immunoassay according to the double 
antibody solid phase technique (13) within 5 months after completion of the 
experiment. Serum was stored at -20°C until analysis, and all samples of one 
subject were analysed in one run. 
Statistical evaluation 
For statistical evaluation mean changes per group over the test period were 
compared between groups using a 2-tailed Student's t-test. 
RESULTS 
Results of insulin and glucose measurements in fasting and postprandial 
blood are given in Tables 2 and 3. 
Fasting plasma glucose levels at the end of the control period were low in both 
experiments and equal in all dietary groups. Fasting serum insulin levels at 
the end of the control period were on the whole somewhat lower in the second 
experiment than in the first, but differed little between the groups in each 
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experiment. 
The fasting plasma glucose and serum insulin levels showed little change over 
the course of the test period on any of the diets. 
Carbohydrate-tolerance is usually evaluated by means of a uniform glucose 
load. In the present experiment, however, we measured the glucose and insulin 
response to lunches of a composition that differed for the different diet 
groups. The composition of the test lunches is given in Table 1, together with 
the overall composition of the test diets. 
The differences between the groups in fatty acid composition of the test 
lunches were greater then the differences between the diets as a whole. The mean 
difference in fat content between the high fat meals (groups HIPUF and HISAT) 
and the low fat meals (group LO) in the first experiment was on average 20 g; 
the difference between the moderate and the low fat meal in the second experi-
ment was 12 g of fat on average. In both cases this was mainly compensated for 
by starch, at a rather constant level of dietary fiber intake. 
Little or no rise in plasma glucose was observed after any of the test-lunches. 
The only significant postprandial change in plasma glucose was the rise after 
the high-carbohydrate LO lunch in the fifth week of the second experiment. No 
such effect was observed on this diet, however, in week one or week 13 in the 
same experiment. 
The serum insulin levels one hour after the test lunches were twice as high 
in the high carbohydrate group LO as in the high fat groups HIPUF and HISAT in 
the first experiment. In the second experiment the insulin response in group LO 
was equal to that in the moderate fat group MOD. 
The insulin response to the test lunch was greater at the end of the test 
period than at the start of the test period in all 3 groups examined in the 
first experiment; the differences between the groups, however, were not 
statistically significant. The same was found for the two diet groups examined 
in the second experiment. 
DISCUSSION 
Epidemiological studies have revealed that the prevalence of diabetes is 
lower in countries with a high starch consumption than in countries with a high 
fat or high sugar intake (14, 15). A low incidence of diabetes was also found 
among Eskimos, who consume a diet, low in carbohydrate but very high in poly-
unsaturated fat (16, 17). Other studies suggest that diabetes becomes more 
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prevalent as the intake of dietary fiber decreases (18). Of course, such 
results cannot be accepted as evidence that high-starch, high-fiber or high-
polyunsaturate diets can prevent disturbances of carbohydrate metabolism. The 
observed differences in the prevalence of disease might have been caused by 
other, confounding factors, such as obesity or total energy intake, which are 
both known to influence carbohydrate metabolism (14, 19). Aspects of life style 
other than diet could also be important. Therefore, controlled experiments are 
necessary to establish the influence of single dietary factors. 
In our experiments, we did not find lower fasting or postprandial glucose 
or insulin levels on a high-carbohydrate, low-fat diet, compared with diets 
moderate or high in fat. This appears to contradict certain earlier studies 
(1-3). However, the design of our studies was different in several respects. 
Firts, carbohydrate tolerance is usually measured by means of an oral glucose 
tolerance test. In contrast, we measured carbohydrate tolerance by means of 
test-lunches of the same general composition as the test diet as a whole, and 
thus different for each dietary group. Second, most of the dietary research on 
carbohydrate metabolism in man has been carried out with diseased subjects, 
especially diabetic and/or obese patients. In contrast, our subjects were in 
general lean and they had normal fasting glucose and insulin levels. They 
exhibited practically no elevation of plasma glucose concentrations after a 
test-lunch, whatever its carbohydrate content. This indicates that their carbo-
hydrate tolerance was excellent. Hence, comparisons of our results with those 
obtained in patient populations are probably not justified. We will therefore 
limit the following discussion to studies with healthy subjects. 
One of the few studies on carbohydrate metabolism that utilized regular 
foodstuffs is the experiment of Cohen (20) with 15 healthy adult human 
volunteers. He reported a lowering of fasting glucose levels (-10 mg/dl) and a 
lowering of glucose curves after an oral glucose load when fat in the diet was 
replaced by starch, mainly from bread, but not when fat was replaced by sugar. 
No data on dietary fiber consumption were given. It is conceivable that the 
lower glucose levels on the bread diet were due to the high fiber content of 
such diets rather than to their starch content. High-fiber diets have been 
reported to reduce plasma glucose and insulin concentrations after a meal (21). 
Brodribb and Humphreys reported that long term consumption of bran also lowered 
fasting blood glucose curves in non-diabetic patients after a standard oral 
glucose load (22). 
Differences in fiber intake probably do not play a role when test-diets are 
given as liquid formulas. In an experiment of Reaven and Olefsky (23) with 
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liquid formula diets, fat was replaced by carbohydrates, while at the same time 
the proportion of polyunsaturated fat was increased. This led to a small 
increase in postprandial glucose concentrations and a more striking increase in 
postprandial insulin concentrations. No change in preprandial glucose concentra-
tions was observed, but preprandial insulin levels were ca. 15 uU/ml higher on 
the high carbohydrate diet. However, the test period lasted only four days. 
Other studies with liquid formula diets did not measure actual postprandial 
insulin or glucose levels, but instead employed a standard glucose load. Such 
tests did show a more favorable effect of replacing fat by carbohydrate. Thus 
Brunzell et al. (24) and Wigand et ai. (3), found lower insulin and glucose 
curves after oral glucose load on very high carbohydrate diets than on very high 
fat diets. In these studies fasting glucose levels were lower on the high carbo-
hydrate diets, but the difference was small (4-6 mg/dl) and the effects on 
fasting insulin levels in the two experiments were in opposite directions. 
Anderson et al. (25), who exchanged glucose for corn oil in liquid formula 
diets, also found lower glucose curves after an oral glucose load if the 
glucose content of the diets was higher. Fasting glucose concentrations, 
however, were not different on the various diets. In an experiment of Hales et 
al. (2) high carbohydrate diets caused lower fasting insulin and glucose con-
centrations and lower glucose curves after an oral glucose load than diets 
containing more fat and protein. Insulin curves, however, did not differ. 
Wilkerson et al. (1) also reported lower fasting glucose levels on high carbo-
hydrate diets in males, but not in females, and lower glucose curves after an 
oral glucose load in both males and females. In both experiments carbohydrates 
were replaced by fat plus protein. This makes it difficult to evaluate the 
results, because fat and protein may interact in determining blood glucose 
concentrations (26). 
As far as the influence of the type of dietary fat on carbohydrate tole-
rance is concerned, we could not detect a favorable effect of polyunsaturated 
fatty acids compared with saturated fatty acids. This is in agreement with the 
results of Nestel (27). 
The discrepancies between our results for high-carbohydrate diets and those 
discussed above might be explained by our use of normal foodstuffs instead of 
liquid formula diets, the use of a 'lunch tolerance test' that differed in 
carbohydrate content between the diets under study instead of a uniform glucose 
load and by the type of subjects. Liquid formula diets are usually very low in 
dietary fiber, and glucose tolerance tests are hardly representative for a 
normal physiological stimulus. Therefore, it is questionable to what extent the 
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results of such diets can be extrapolated to populations consuming regular 
diets. Our results seem to indicate that neither the type nor the amount of 
dietary fat has a strong influence on carbohydrate tolerance in young healthy 
subjects. However, our results might not be valid for older people, or obese 
or hyperlipidaemic patients whose glucose tolerance may be impaired. Also, our 
results do not exclude beneficial effects of changes in those dietary components 
that were forcibly held constant in our experiments, such as dietary fiber. 
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ABSTRACT 
In the course of four controlled experiments on the effect of specific 
dietary components on cardiovascular risk factors, the effects on blood pressure 
of various sources of dietary fiber, of type and amount of dietary fat, and of 
animal versus plant protein were measured in young normotensive volunteers. In 
each of the four experiments a group of 50-75 healthy student volunteers 
received a control diet for 1| to 2| weeks. They were then randomized into 
subgroups which received various test diets for periods ranging from 4-12 weeks. 
In each experiment one group received the control diet throughout the whole 
experimental period. Diets differed between groups in one dietary component 
only. All foodstuffs were weighed out individually according to each person's 
energy needs. Body weights and Na intake were controlled. In the fiber experi-
ment the control diet had a relatively low fiber content. Test diets consisted 
of the low fiber control diet supplemented with coarse wheat bran, isolated 
citrus pectin or a large amount of vegetables and fruits. In the protein experi-
ment sixty-five percent of total protein was replaced by casein or by soy pro-
tein. In fat experiment 1 the control diet was moderate in total fat but con-
tained 11% of daily energy as polyunsaturated fatty acids (PUFA). The test 
diets were a low fat diet containing 3% of daily energy as PUFA; a high fat 
diet containing 3% of daily energy as PUFA and a high fat diet in which half of 
the total fat was polyunsaturated. In fat experiment 2 the moderate fat control 
diet and the low fat diet were tested again for a longer period. Initial blood 
Supported by the Netherlands Heart Foundation (Grants No. 75.035 and 77.082) 
and the Netherlands Institute for Dairy Research. 
83 
pressures were about 120 mm Hg systolic and 70 mm Hg diastolic. Both systolic 
and diastolic blood pressure decreased during the test period in all four 
experiments on almost every diet, including the control diets, by about 0-5 mm 
Hg. However, changes in blood pressure over the test period were never 
significantly different between the test groups and the control groups. Thus, 
none of the investigated dietary factors had a demonstrable effect on blood 
pressure in young normotensive persons. 
INTRODUCTION 
Hypertension is one of the most important risk factors for the development 
of cerebrovascular, coronary and aortic atherosclerosis (1, 2) and is present 
in about 15% of the adult American population (3). It has been clearly 
established that antihypertensive drug treatment reduces not only the morbid 
complications of hypertension but also total mortality (3, 4). For obvious 
reasons, however, primary prevention of the disease would be preferable to 
widespread drug treatment. 
In many primitive communities, hypertension is virtually absent, because 
the rise of blood pressure with age which is common to Western societies does 
not occur (5, 6, 7). Among the many determinants of life style, several authors 
have stressed the importance of diet in the emergence of widespread hyper-
tension in affluent societies. There is good evidence for a role for dietary 
sodium in the development of high blood pressure (for a review see: 8); it has 
also been suggested that a high intake of potassium might be protective (8, 9). 
In addition to sodium and potassium intake other dietary factors may be 
important. There is evidence that dietary linoleic acid will lower blood 
pressure in hypertensive animals (10) while epidemiological studies and 
controlled trials in man also suggest a slight beneficial effect (11-14). 
Other studies suggest a beneficial effect on blood pressure of dietary fiber 
(15), or a deleterious effect of sugar (16) and animal products (17). However, 
controlled studies in man on the effect of fiber or animal products on blood 
pressure are rare or absent. 
In the course of four controlled trials on the effect of specific dietary 
components on cardiovascular risk factors we have measured the effects of 
various sources of dietary fiber, type and amount of dietary fat and type of 
protein on blood pressure in young, normotensive volunteers. It was found that 
none of these factors had a measurable effect on blood pressure. 
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METHODS 
The primary aim of the four experiments was to test the effect of various 
dietary components on cholesterol metabolism. The details of each trial have 
been described elsewhere (18-22; Brussaard et ai., in preparation). The general 
design of the experiments was as follows (Table 1). 
TABLE 1. GENERAL DESIGN OF EXPERIMENTS 
Group 
Control group 
Diet group A 
Diet group B 
Diet group C 
Control period 
(11 - n wk) 
control diet 
control diet 
control diet 
control diet 
Test period 
(4 - 13 wk) 
control diet 
test diet A 
test diet B 
test diet C 
The subjects were young healthy student volunteers; their age ranged from 18 to 
30 years (median: 21 years). 
In each of the four trials a group of 50-75 volunteers received a control diet 
for 1J to Z\ weeks. They were then randomized into subgroups stratifying for 
initial serum cholesterol level, male/female ratio and energy intake. The sub-
groups received various test diets for periods ranging from 4 to 12 weeks. 
Diets differed between groups in one dietary component only; one group always 
received the control diet throughout the test period as a check against base-
line drift. Throughout each experiment all foodstuffs were individually weighed 
out and supplied according to each person's energy needs. 
Dietary composition 
Fiber experiment (18). In the fiber experiment the control diet was a relative-
ly low-fiber diet with a mean intake of 18 g total dietary fiber per day. 
During the test period of five weeks one group continued on the control diet. 
A second group received 43 g dietary fiber per day on the average, which came 
mainly from vegetables and fruit. A third group received the low fiber diet 
plus on the average 9 g isolated citrus pectin NF (degree of esterification 78%) 
per day so that the total dietary fiber intake was 28 g per day on average. 
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A fourth group received the low-fiber control diet enriched with on the average 
38 g coarse wheat bran per day (dietary fiber content 50 g/100 g fresh weight); 
mean intake of total dietary fiber in this group was 37 g/day. Consumption of 
polygalacturonic acid (pectin) amounted to 1.7, 7.5, 8.8 and 1.7 g per day in 
the control, vegetables/fruits, citrus pectin and bran group respectively. The 
diets provided 37% of total energy intake as fat (4% of total energy as lonoleic 
acid), 13% as protein, 48% as carbohydrate (23% of total energy as oligo-
saccharides) and 142 mg cholesterol/4.2 MJ. 
Protein experiment (19, 20). In the protein experiment all diets contained 38% 
of total energy as fat (8% of total energy as linoleic acid), 47% as carbohy-
drates (23% of total energy as oligosaccharides) and 12-13% as protein. 
Cholesterol intake was 146 mg/4.2 MJ per day. Sixty five percent of the protein 
in the diets consisted of casein or soy protein isolate or a 2:1 mixture of 
casein and soy protein isolate (control diet). The test period lasted 4 weeks. 
Fat experiment l (21). The control diet in this experiment contained 11% of 
total energy as polyunsaturated fat (PUFA); in total, fat provided 30% of daily 
energy. A low fat, low PUFA diet provided 22% of energy as total fat (3% of 
daily energy as PUFA); a high fat, high PUFA diet provided 40% of daily energy 
as total fat (19% of daily energy as PUFA) and a high fat, low PUFA diet 
provided 39% of daily energy as total fat (3% of daily energy as PUFA). The 
test period lasted 5 weeks. In all diets protein provided 13% of daily energy, 
while carbohydrates made up the total energy balance. Intake of oligosacchari-
des was 23% of daily energy in all groups; cholesterol intake was 110 mg/4.2 MJ. 
Fat experiment 2 (22). In the second fat experiment the control diet and the 
low fat, low PUFA diet of fat experiment 1 were tested again, but this time the 
test period lasted 12 weeks instead of 5 weeks. 
Intake of Na and K 
Customary amounts of salt were added to dishes by us during preparation. No 
further addition of salt was permitted. Na en K content of the diets were 
measured by analysis of double portions (18). Diets provided on the average 170, 
168, 171 and 190 mmol Na per day and 98, 58, 83 and 90 mmol K per day in the 
fiber, protein fat 1 and fat 2 experiment respectively. There were only minor 
differences between groups and between control and test period in each experi-
ment, with the exception of the fiber experiment: the vegetables/fruits diet 
contained more Na and K and the bran diet more K than the control diet, 
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resulting in Na/K ratios of 0.90, 0.95, 1.11 and 1.22 in the vegetables/fruits, 
bran, control and pectin diet respectively. 
As an additional check on Na and K consumption, 24 hour urinary excretion of Na 
and K was measured in the protein and fat 1 experiment. The results confirm the 
dietary analysis data (Table 2). 
TABLE 2. EXCRETION OF Na AND K IN URINE DURING THE CONTROL AND TEST PERIOD OF 
THE VARIOUS EXPERIMENTS (mean ± SD). 
Na 
Group Control Change over+ Control Change over 
period test period period test period 
t) 
(mmol/day) 
Fiber experiment 62 *) *) «) x) 
Protein experiment 
Cassoy (control) group 
Casein group 
Soy group 
20 
25 
24 
195 ±60 
188 ±51 
183 ± 48 
-23 ±67 
-21 ±58 
-14 ±69 
55 ±18 
55 ±12 
52 ± 9 
21 ±23 
19 ±17 
17 ±20 
Fat experiment 1 
Moderate f a t , high PUFA 
(control) group 
Low f a t , low PUFA group 
High f a t , high PUFA group 
High f a t , low PUFA group 
Fat experiment 2 
15 
16 
15 
14 
35 
165 ±51 
156 ±57 
153 ±82 
148 ±53 
x) 
11 ±64 
40 ±49 
8± 77 
6 ±30 
H ) 
78 ±18 
79 ±21 
76 ±19 
76 ±22 
H) 
3± 17 
8 ±14 
-9 ±23 
-8 ±20 
H) 
x) not measured 
+) duration of control period: fiber, fat 1, fat 2: 2| week; protein: lj week. 
+) duration of test period: fiber 3 weeks; protein A weeks; fat 1: 4 weeks; 
fat 2: 13 weeks. 
87 
At the end of the test period in the fat experiment 1, the excretion of Na was 
slightly higher in the low fat low PUFA group than in the other groups. 
However, the excretion of K was also higher, so that the Na/K ratio was not 
different from the other groups. In the protein experiment there were only 
minor differences between groups. 
Body weights 
None of the participants had body fat percentages above 23% (male) or 30% 
(female). From the 60-100 subjects who volunteered per experiment 2-6 persons 
had to be rejected on this criterium 
For the combined population the P5, P50 and P95 for body weights for females 
were 50, 60 and 73 kg; for males these values were 60, 71 and 84 kg. 
For males these values are slightly lower than the body weights of male North 
American subjects (23); for females the values agree well. 
In each experiment body weight was recorded weekly and energy intake was 
adapted when necessary to maintain stable weight. Mean change in body weights 
per diet-group from start to finish of the test periods was -0.2 to +0.3 kg in 
the fiber experiment; -1.0 to -1.6 kg in the protein experiment; -0.4 to -0.8 
in fat experiment 1 and -1.3 to -1.6 kg in fat experiment 2. 
Measurement of blood pressures 
Blood pressures were measured before the start of each experiment for 
familiarization of the participants with the measurement and elimination of 
hypertensives. Measurement was repeated at the end of the control period and in 
the test period; after 3 weeks in the fiber experiment, after 4 weeks in the 
protein experiment and fat experiment 1, and after 13 weeks in fat experiment 2. 
From all subjects who volunteered for these experiments only one or two in each 
trial exceeded our criteria for participation (150 mm Hg systolic and/or 95 mm 
Hg diastolic in the protein experiment and fat experiment 2; 90 mm Hg diastolic 
in the fiber experiment and fat experiment 1). No restrictions were made as to 
performing physical activity, eating or smoking prior to the blood pressure 
determinations. (Forty-three out of the 139 males and 14 of the 86 females 
smoked cigarettes; however, only 5 subjects, all males, smoked more than 15 
cigarettes per day). 
The measurement was performed in a quiet room in the department after a 
5-10 minute rest. During the measurement the subjects were sitting (fiber 
experiment) or lying down (protein, fat experiments 1 and 2). 
In the fiber experiment the mean of two consecutive measurements on one day was 
recorded. In the protein and fat experiments blood pressure was measured twice 
on two consecutive days and the mean of these four measurements was used. Care 
was taken that each person was measured at the same time of day during all 
measurements and that the subjects in different diet groups were measured in 
random order. All measurements in each trial were performed by the same person. 
An automatic recording sphygmomanometer type BE 207S (Elag, Kb'ln, Germany) 
which employs phase IV (Korotkoff) as diastolic blood pressure was used. This 
instrument uses an inflated cell inside the cuff to detect movements of the 
arterial wall. The pressure waves are converted into electronic signals by 
means of a microphone. The instrument was recalibrated periodically against a 
mercury column manometer. 
For all subjects combined, the median blood pressure prior to the experi-
ments was 115/68 mm Hg (systolic/diastolic) for females and 129/67 mm Hg for 
males. The 5th-95th percentile ranges were 93-132/50-85 (systolic/diastolic) 
for females and 107-156/46-88 for males. These values are in excellent agree-
ment with values for the general Dutch population in this age group (24) and 
are similar to what has been reported for North-American populations (23). 
The subjects in fat experiment 2 had somewhat higher mean systolic and diastolic 
blood pressures than in the other groups, but were still well within normal 
range. 
For statistical evaluation mean changes per group over the test period were 
compared between groups using 2-tailed Student's t-test. 
RESULTS 
Mean blood pressures per diet group at the end of the control periods and 
mean changes per group over the various test periods are given in Table 3. 
In all four trials systolic blood pressures decreased in all test groups as 
well as in the control group. In almost all cases these changes were significant-
ly different from zero. However, the differences in blood pressure changes over 
the test period between test groups and the control group were not significant 
in any experiment. 
Diastolic blood pressures decreased also in all test groups as well as in 
the control group, with the exception of the change in the vegetables/fruits 
group in the fiber experiment (+1 mm Hg). But again the differences in blood 
pressure changes over the test period between test groups and the control group 
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TABLE 3. EFFECT ON BLOOD PRESSURE IN NORMOTENSIVE SUBJECTS OF DIETARY FIBER 
FROM VARIOUS SOURCES (Stasse-Wolthuis et al., 1980), CASEIN AND SOY 
PROTEIN (van Raaij et al., 1980) OR DIFFERENT TYPES AND AMOUNTS OF 
DIETARY FAT (Brussaard et al., 1980) (mean ± SD) 
Systolic 
Control Change over 
period') test period2) 
Diastolic 
Control Change over 
period') test period2) 
Group 
Fiber experiment 
Low fiber (control) 
Vegetables/fruits 
Citrus pectin 
Bran 
n 
16 
15 
15 
16 
(mean 
+SD) 
124 ± 
117 ± 
125 ± 
128 ± 
12 
15 
15 
18 
(mean ± 
-4.6 ± 
-2.0 ± 
-1.1 ± 
-1.0 ± 
SD) 
(mm 
9.3 
7.4 
7.0 
10.1 
Hg) 
(mean 
± SD) 
63 ± 11 
58 ± 14 
59 ± 11 
65 ± 8 
(mean ± SD) 
-4.4 + 10.1 
+1.2 + 11.4 
-0.5 ± 5.8 
-3.4 + 11.0 
Protein experiment 
Cassoy (control) 
Casein 
Soy 
20 
25 
24 
127 ± 12 
123 ± 11 
124 ± 15 
-3.0 ± 6.0 
-3.1 ± 8.9 
-2.5 ± 5.9 
73 ± 8 
69 ± 10 
69 ± 11 
-5.8 + 7.6 
-2.7 ± 6.6 
-2.5 ± 6.1 
Fat experiment 1 
Moderate fat, high 
PUFA (control) 
Low fat, low PUFA 
High fat, high PUFA 
High fat, low PUFA 
Fat experiment 2 
Moderate fat, high 
PUFA (control) 
Low fat, low PUFA 
15 
16 
15 
14 
17 
18 
119 ± 
122 + 
116 ± 
115 ± 
130 ± 
131 ± 
12 
11 
15 
17 
10 
6 
-4.8 ± 
-5.0 ± 
-5.1 ± 
-3.3 ± 
-7.1 ± 
-5.5 ± 
10.3 
6.0 
5.4 
6.4 
6.4 
5.9 
67 ± 
64 ± 
65 ± 
65 ± 
80 ± 
79 ± 
6 
9 
7 
9 
10 
8 
-3.4 + 
-4.4 + 
-2.7 ± 
-3.1 ± 
-8.3 + 
-10.5 ± 
6.7 
4.9 
8.1 
5.7 
9.2 
11.6 
1) 
2) 
Duration of control period: fiber, fat 1, fat 2: 2j week; protein lj week. 
Duration of test period: fiber 3 weeks; protein 4 weeks; fat 1: 4 weeks; 
fat 2: 13 weeks. 
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never attained statistical significance. 
DISCUSSION 
Because of the importance of primary prevention of hypertension attention 
has been focussed on dietary changes to lower blood pressure. Kempner (25) has 
shown that a rice-fruit diet low in sodium can lower blood pressure in hyper-
tensive patients by as much as 30 mm Hg. There is also evidence from recent 
controlled trials (26, 27) that a modest reduction in salt intake can produce 
a modest reduction of blood pressure in hypertensive patients. The effect of 
changes in other dietary components has not been satisfactorily tested. In our 
experiments we found no effect of changes in intake of dietary fiber, type of 
protein or type or amount of fat on blood pressure in young normotensive men 
and women. 
Fiber 
It has been suggested that a high-fiber diet could lower blood pressure 
through its high content of potassium (9, 28). A lowering of blood pressure by 
4-8 mm Hg systolic and 3-4 mm Hg diastolic on diets rich in dietary fiber 
(mainly from cereals) was reported by Wright et ai. (15). Kelsay et ai. (29) 
reported a lower diastolic blood pressure during a high fiber diet than during 
a low fiber diet. Their conclusion however, was due to misinterpretation of 
results that could be completely accounted for by regression towards the mean. 
In our experiment with dietary fiber the effect on blood pressure of the 
vegetables/fruits diet and the bran diet was not different from the low-fiber 
control diet, despite the lower Na/K ratio of these test diets. The intake of 
K-rich foodstuffs on these diets was quite high: the subjects consumed on 
average 600 g apples plus 400 g cooked vegetables plus 170 g tomatoes or 38 g 
bran per day. We think it would be very difficult to increase the potassium 
intake further if only natural foodstuffs are to be employed. 
Protein 
Armstrong et al. (30) and Sacks et ai. (17) suggested from their studies 
with vegetarians that a higher consumption of animal protein or animal products 
is accompanied by higher blood pressures. To our knowledge no controlled 
experiments on the effect of type of protein on blood pressure in humans have 
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been published. We found no difference in effect on blood pressure of a diet 
rich in animal protein (casein) or plant protein (soy). 
Body weights decreased to some extent in this experiment and this is known to 
affect blood pressure (31). However, it seems unlikely that this could have 
interfered with the results because the decrease in body weight was small and 
was very similar in all 3 diet groups. 
Fat 
A lowering of blood pressure on diets rich in linoleic acid has been 
reported by several authors (12-14, 32). Iacono (13) reported that a diet 
containing 25% of total energy as fat and 6.5% as linoleic acid lowered blood 
pressure by 13 mm Hg systolic and 7 mm Hg diastolic in normotensive persons 
compared with their habitual diet; systolic blood pressure remained low after 
switching to a diet with 35% of total energy as fat and 9% as linoleic acid, 
but diastolic blood pressure increased by 3 mm Hg. It was concluded that 
lowering the intake of dietary fat and raising the intake of polyunsaturated 
fat had a beneficial effect on blood pressure. Although blood pressures were 
within the normal range they were higher than in our participants, which may 
partially account for the discrepancy with our results. 
Judd et ai. compared the effect of diets containing 43 and 25% of total 
energy as fat, each with P/S ratios of 0.3 and 1. They conclude that a lowering 
of total fat intake as well as a rise in linoleic acid consumption can lower 
blood pressure. Maximum effects were observed in the group with the highest 
initial blood pressure level. 
In the experiment of Stern et ai. (14) blood pressure was lowered in over-
weight hypertensives on a linoleic acid rich diet. However, the interpretation 
of this experiment is hampered by the absence of details on diet composition and 
control of nutrient intake. There was no control group in this experiment; thus 
it is possible that the experimental conditions themselves caused a lowering of 
blood pressure, independent of dietary composition. 
Oster et ai. (12) reported a small tendency towards lower blood pressures 
(2-4 mm Hg) on a diet containing 70 g cornoil per day in subjects with blood 
pressures comparable to our participants. 
Weak although significant negative correlations between C 18:2 content of 
adipose tissue and blood pressure (r = -0.11 for systolic and -0.07 for dia-
stolic blood pressure) were found in an epidemiological study (11). In contrast 
to these observations we found no effect on blood pressure of diets rich in 
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linoleic acid, nor did we find an effect of the amount of dietary fat. As 
changes in body weight in the fat experiments were slight and very similar in 
the different diet groups, it does not seem likely that this could have dis-
turbed our results. Also a confounding influence of Na consumption is unlikely, 
because Na-intake was controlled in all four trials. 
Although we did not find an effect of dietary fiber, fat or protein on 
blood pressure, our results do not rule out the possibility that these dietary 
components can indeed lower blood pressure. 
Firstly, the small number of participants in this type of controlled 
experiment and the large range of individual changes in blood pressure, result-
ing in a poor estimate of the change difference between groups, render a con-
siderable risk of committing a type II error (i.e. not detecting an actually 
existing difference between dietary effects). When testing the difference of 
two group means, two-sided on for example 5% level, the power of the test (i.e. 
the probability of rejecting the null hypothesis of no effect in case of a real 
effect) depends on the magnitude of the true effect and the standard error of 
its estimate. In experiments like ours, a typical value of the standard 
deviation of blood pressure change is SD=7. Kelsay (29), Morgan (26) and 
Iacono (13) found lower SD's, but similar values are reported by Parijs (27), 
Oster (12) and Stern (14). With about 16 persons per group, the probability of 
detecting a difference between diet groups of 2 mm Hg is only about 11%; for 
4 mm Hg this is 31% and for 7 mm Hg it is 75%. 
It should be noted that a lowering of blood pressure by only 4 mm Hg was 
found to cause a marked reduction in mortality from all causes in the Hyper-
tension Detection and Follow-up Program (3). To increase the power of the test 
up to 80% for a difference of 2 mm Hg between the diet groups, each group has 
to comprise about 200 persons. In our experiment the probability that we missed 
a difference of 7 mm Hg is only 25%, but almost 70% that we missed a 4 mm Hg 
difference. Thus we must face the possibility that we missed an effect of this 
magnitude purely by chance. 
Secondly, our participants were young healthy men and women, who were not 
obese and had low to normal blood pressures. This makes it perhaps more 
difficult to lower blood pressures. The investigated dietary components might 
be effective in lowering blood pressure in older persons with higher blood 
pressure levels, as was also indicated in the experiment of Judd et ai. (32). 
Thirdly, the relatively short duration of our experiments could obscure an 
effect of diet on blood pressure in the long run. 
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In summary, we have not been able to show an effect of dietary fiber from 
different sources, type of protein or type and amount of dietary fat on blood 
pressure in normotensive subjects. However, the possibility that these dietary 
components can influence blood pressure in persons with higher initial levels 
of blood pressure or to an extent of less than 5-7 mm Hg in young normotensive 
people cannot be ruled out. 
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Bijlage. Voeding en hart- en vaatziekten, een verzekering met slechts 
gedeeltelijke dekking. 
Dit proefschrift gaat over het verband tussen voeding en hart- en vaat-
ziekten. Dat onderwerp houdt veel mensen bezig en er is de laatste jaren dan 
ook veel over te doen geweest. In krante-artikelen, t.v.-uitzendingen en 
reclame worden nogal eens tegenstrijdige adviezen de wereld ingestuurd, 
varierend van: "allemaal onzin, eet maar gewoon wat je lekker vindt" tot 
reclame voor een bekende dieetmargarine, ronduit "goed voor hart- en bloed-
vaten". 
In dit hoofdstuk wil ik proberen enige duidelijkheid te scheppen over de 
vraag of de voeding een rol kan spelen bij het verkleinen van de kans op een 
hartinfarkt, en zoja hoe belangrijk die rol is. 
Hart en bloedvaten 
Het menselijk lichaam heeft de bloedsomloop nodig om het bloed bij alle 
delen van het lichaam te brengen. Dit heeft o.a. tot doel om voedsel en zuur-
stof naar de lichaamscellen te brengen en afvalstoffen af te voeren. 
Het hart is de motor van de bloedsomloop. Via de slagaders wordt het bloed door 
het lichaam verspreid en via de aderen wordt het weer terugqevoerd naar het hart. 
Ziekten van hart en bloedvaten 
Net als alle andere lichaamsdelen kunnen hart en bloedvaten door verschil-
lende ziekten aangetast worden, b.v. ontstekingen of rheuma, of er kunnen al 
bij de geboorte bepaalde afwijkingen aanwezig zijn. Deze ziektes kunnen al dan 
niet fatale gevolgen hebben. De meeste hart- en vaataandoeningen, waarbij ge-
vaar voor het leven dreigt, zijn het gevolg van atherosclerose (populair gezegd: 
aderverkalking) in de slagaders die de spierwand van het hart zelf van voedsel 
en zuurstof voorzien of van atherosclerose in de slagaders van de hersenen. 
Wat is atherosclerose? 
Atherosclerose is het verschijnsel dat in de wand van bloedvaten vetachtige 
stoffen -o.a. cholesterol- zich ophopen, waardoor de doorstroming van het bloed 
wordt belemmerd. (Er kan ook afzetting van kalkachtige stoffen plaatsvinden; 
vandaar de minder juiste naam aderverkalking). Het proces van atherosclerose 
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begint met kleine beschadigingen in de vaatwand. Deze beschadigingen kunnen 
b.v. veroorzaakt worden door koo!monoxide (een gevolg van sigaretten roken) of 
door hoge bloeddruk. Op de plaats van beschadiging kunnen zich gemakkelijk 
stoffen uit het bloed ophopen (b.v. cholesterol). Ook kan zich op zo'n aange-
tast plekje een bloedstolsel vastzetten. Daardoor raakt de doorstroming van 
het bloed nog meer belemmerd. In ernstige gevallen kan een bloedvat zelfs 
helemaal verstopt raken. Wanneer een slagader van het hart (of de hersenen) 
geheel verstopt is, krijgt een deel van het hart (of de hersenen) geen voedings-
stoffen en zuurstof meer en houdt op te funktioneren. Als dit in het hart ge-
beurt spreken we van een hartinfarkt; in de hersenen van een beroerte. Van de 
plaats en grootte van het betrokken gebied hangt het af, of het infarkt dode-
lijk is of niet. 
Wanneer een slagader van het hart gedeeltelijk verstopt is, kan dit in bepaalde 
gevallen ook al leiden tot pijn en benauwdheid (of wanneer het in de hersenen 
is tot bepaalde verlammingsverschijnselen). Vooral bij inspanning kan de hart-
spier dan meer zuurstof nodig hebben dan er met het bloed door de vernauwde 
slagader kan worden aangevoerd. Dit komt echter niet altijd duidelijk tot 
uiting; vandaar dat een hartinfarkt soms volkomen onverwacht optreedt. 
Overigens kunnen ook nieren en andere organen afwijkingen vertonen ten gevolge 
van bloedvatvernauwingen. 
Hoeveel mensen hebben eigenlijk hart- en vaatziekten? 
Uit rapporten van het Ministerie van Volksgezondheid en Milieuhygiene en 
van het Centraal Bureau voor de Statistiek blijkt, dat bij 19% van alle perso-
nen tussen 20 en 65 jaar die per jaar blijvend arbeidsongeschikt worden ver-
klaard, een hart-/vaatziekte hiervan de oorzaak is. Vijfenveertig procent van 
alle sterfgevallen per jaar in Nederland wordt veroorzaakt door hart- en vaat-
ziekten. Van de mensen die aan hart- en vaatziekten overlijden is 13% jonger 
dan 60 jaar en 8% is tussen de 60 en 65 jaar. 
De sterfte ten gevolge van hart- en vaatziekten is bij mannen jonger dan 60 
jaar 4 a 6 maal zo hoog als bij vrouwen van dezelfde leeftijd. 
Risikofaktoren voor hart- en vaatziekten 
Er is veel onderzoek verricht om na te gaan of mensen die een hartinfarkt 
krijgen in bepaalde opzichten verschillen van mensen die geen hartinfarkt 
krijgen. Daarbij bleek, dat er zeer veel faktoren zijn die samengaan met een 
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verhoogd risiko voor hart- en vaatziekten, b.v. hoge bloeddruk, verhoogd 
cholesterolgehalte van het bloed, sigaretten roken, oudere leeftijd, mannelijk 
geslacht, bepaalde erfelijke aanleg, suikerziekte, misschien ook overgewicht en 
geringe lichamelijke activiteit, enz. enz. Dergelijke faktoren worden risiko-
faktoren voor hart- en vaatziekten genoemd. Het is niet bekend of al deze 
faktoren ook werkelijk het proces van atherosclerose beTnvloeden. Er kunnen ook 
faktoren bij zijn, die werken als het rode lampje voor het oliepeil in een 
auto, dat gaat branden als het oliepeil te laag is. 
Als we het lampje losdraaien zodat het niet meer brandt, betekent 
dat nog niet dat het oliepeil weer in orde is. Met andere woorden: het is niet 
zonder meer zo, dat als we een risikofaktor verlagen dan ook de kans op een 
hartinfarkt afneemt. 
De risikofaktoren die het belangrijkste zijn voor de kans op een hartinfarct 
zijn het roken van sigaretten, hoge bloeddruk en een verhoogd gehalte 
cholesterol in het bloed. Het is zeer waarschijnlijk dat deze faktoren ook 
echt het proces van atherosclerose beTnvloeden: naarmate het cholesterolgehalte 
in het bloed hoger is, kan meer cholesterol in de vaatwand afgezet worden. 
Door hoge bloeddruk en door koolmonoxide en nicotine, die door het roken van 
sigaretten in het bloed komen, wordt de wand van een bloedvat steeds een beetje 
beschadigd. Daardoor kunnen weer gemakkelijker stoffen in de vaatwand afgezet 
worden en bloedstolsels ontstaan met de hierboven beschreven gevolgen. 
wanneer we nu willen zorgen dat er minder hart- en vaatziekten voorkomen lijkt 
het dan ook logisch om deze risikofaktoren te veranderen. Inderdaad is ook ge-
bleken dat wanneer iemand stopt met roken, of wanneer de bloeddruk door b.v. 
medicijngebruik daalt, de kans om een hartinfarkt te krijgen of om aan een 
hartinfarkt te overlijden afneemt. Datzelfde geldt voor verlaging van het 
cholesterolgehalte in het bloed. 
Jets meer over cholesterol in het bloed 
De laatste jaren is duidelijk geworden, dat niet alleen het 
totale cholesterolgehalte in het bloed belangrijk is voor het 
mogelijke risiko. 
Cholesterol wordt in het bloed getransporteerd in de vorm van 
lipoproteinen. Dat zijn deeltjes, die bestaan uit cholesterol, 
andere vetachtige stoffen en eiwitten. Die deeltjes zijn echter 
niet allemaal eender; er zijn zware (high density lipoproteins; 
HDL), lichte (low density lipoproteins; LDL) en zeer lichte lipo-
proteinen (very low density lipoproteins; VLDL). Volgens recente 
100 
H/\RFEN 
V M 0 E K I B I 
BEJWLOEP 
DOORVffiL 
fAaoREM;O.A.; 
NSKX)-
mODREN 
KUNMEK1 
VEfflNDEfl), 
WORDBsl 1 
[CH0LE5TO 
IHETHCER 
fERpOOKjUJ^AWffi] 
CHOl£SfeRCL 
ft PUS, 
MMREHI 
WIN PE VELE 
FACTOREM. 
101 
theorie'en gaat een hoog gehalte cholesterol in LDL gepaard met 
een hoog risiko voor hart- en vaatziekten en een hoog gehalte 
cholesterol in HDL juist met een laag risiko voor hart- en vaat-
ziekten. Het zou b.v. kunnen zijn, dat het cholesterol in LDL 
het kwade werk doet en het dichtslibben van de bloedvaten be-
vordert terwijl de HDL juist cholesterol vervoert dat uit het 
lichaam wordt verwijderd. Een hoog gehalte cholesterol in LDL 
is dus ongunstig, een hoog gehalte cholesterol in HDL gunstig. 
VLDL bevat heel weinig cholesterol en is vooral belangrijk voor 
het transport van vetten. 
Het HDL-cholesterol maakt maar 25 a 35% van het totale chole-
sterol uit. Het totale cholesterolgehalte weerspiegelt dus 
vooral het cholesterol in LDL. 
Omdat het in dit proefschrift vooral gaat over voeding en het cholesterol-
gehalte van het bloed zal daar in het nu volgende iets dieper op worden inge-
gaan. 
Het verband tussen de voeding, het cholesterolgehalte van het bloed en hart- en 
vaatziekten 
De hoogte van het cholesterolgehalte in het bloed wordt behalve door erfe-
lijke aanleg voor een belangrijk deel bepaald door de samenstelling van de 
voeding. Voedingsproeven met mensen hebben aangetoond dat verhoging van het 
gehalte linolzuur (zie kader) in de voeding ten koste van het gehalte verzadigd 
vet het totale cholesterolgehalte in het bloed verlaagt. Waar het natuurlijk om 
gaat is, of dat dan ook daadwerkelijk het ontstaan van hart- en vaatziekten ver-
mindert. En daarover is nogal wat diskussie. 
Jets meer over verzadigd en meervoudig onverzadigd vet 
Vetten en olien zijn naar hun scheikundige samenstelling te 
verdelen in verzadigde, enkelvoudig onverzadigde en meervoudig 
onverzadigde. Meervoudig onverzadigd vet is eigenlijk ook weer 
een verzamelnaam; het belangrijkste bestanddeel ervan is linol-
zuur. Alle vetten en olien bevatten deze drie soorten, maar de 
verhoudingen verschillen nogal. 
In dierlijke vetten (roomboter, rundvet, varkensvet) en in 
de plantaardige vetten palmpitvet en kokosvet overheerst het 
verzadigd vet. 
102 
In de meeste andere plantaardige olien (sojaolie, zonne-
bloemolie) en de traansoorten (levertraan) overheerst het meer-
voudig onverzadigde vet. 
Olijfolie bestaat voor het grootste deel uit enkelvoudig 
onverzadigd vet. 
De verzadigde vetten verhogen het cholesterolgehalte van het 
bloed, de meervoudig onverzadigde vetten verlagen het cholesterol-
gehalte van het bloed en enkelvoudig onverzadigd vet is in dit 
opzicht neutraal. 
Plantaardige margarines worden samengesteld uit plantaardige 
olien die echter vaak gehard worden. Het harden is een chemisch 
proces waarbij een deel van het meervoudig onverzadigd vet wordt 
omgezet in verzadigd vet. Deze margarines bevatten dus minder 
meervoudig onverzadigd vet dan b.v. zonnebloemolie, maar wel 
meer dan b.v. roomboter. Dieetmargarines worden in het algemeen 
bereid uit ongeharde olien, zodat ze een hoog gehalte meervoudig 
onverzadigd vet (ofwel linolzuur) bevatten. 
Betrouwbare studies naar het effekt van voedingsveranderingen op het chole-
sterolgehalte van het bloed kunnen al goed uitgevoerd worden met enkele tien-
tallen proefpersonen en de effekten zijn meestal in enige weken tot maanden 
zichtbaar. Gedegen studies naar het effekt van voedingsveranderingen op ziekte 
en sterfte vereisen een grotere omvang en moeten 1 anger duren. Dat komt omdat 
zelfs in een hoog-risiko groep het aantal nieuwe gevallen van hartaandoeningen 
hoogstens een op de honderd per jaar bedraagt. Na een grondige studie in 1962 
in Amerika werd berekend dat voor een definitieve uitspraak over de kwestie van 
voeding en hart- en vaatziekten een gekontroleerd experiment nodig zou zijn met 
100.000 proefpersonen gedurende 4-5 jaar. Aan deze eisen heeft tot nu toe geen 
enkel onderzoek voldaan en men kan dus, een beetje akademisch, stellen, dat het 
bewijs niet echt geleverd is. 
In voedingsproeven met mensen, waar behalve naar veranderingen in het bloed ook 
is gekeken naar het aantal mensen dat hart- en vaatziekten kreeg, bleek echter 
in bijna alle gevallen, dat hart- en vaatziekten minder voorkwamen op de chole-
sterol verlagende voeding. 
In vele welvarende landen, waaronder Nederland, wordt door de officiele 
instanties dan ook een vermindering van het vetgebruik, vooral verzadigd vet, 
aanbevolen en een verhoging van het gebruik van linolzuur. Een aantal weten-
schappelijke onderzoekers maakt hiertegen bezwaar, omdat er geen bevolkings-
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groepen bekend zijn, die van nature gewend zijn zoveel linolzuur te eten. Men 
vreest voor mogelijk nadelige effekten van zo'n hoge linolzuur consumptie op 
de lange termijn. De dierproeven die over mogelijk nadelige effekten van 
linolzuur zijn gedaan hebben tot nog toe niet duidelijk aangetoond of deze 
vrees gerechtvaardigd of overbodig is. Als alternatief wordt een sterkere 
beperking aanbevolen van het totale vet en cholesterolgebruik, en een verhoging 
van de hoeveelheid zettneel in de voeding. 
De vraag naar mogelijk nadelige effekten op de lange termijn is echter niet de 
enige reden dat het hele thema zo in diskussie blijft. De verschillende belangen 
die een rol spelen zijn hier mede de oorzaak van. 
Welke belangen zijn er in het spel? 
Ekonomische belangen spelen zeker een rol. Dat de producenten van dieet-
margarines en plantaardige olien grote belangen hebben bij de huidige officiele 
aanbevelingen over voeding en hart- en vaatziekten is duidelijk. Wat echter ook 
duidelijk is, is dat een massaal opvolgen van de diverse voedingsadviezen zou 
kunnen leiden tot ernstige gevolgen voor een groot dee! van de rest van de 
levensmiddelenindustrie, waaronder vooral de zuivel-, maar ook de eieren- en de 
vlees- en vleeswarenproducenten. Ook deze belangengroepen roeren zich duchtig 
in de diskussie. 
Er ontstaan ook moeilijkheden als we willen schatten wat het belang voor het 
individu is van het opvolgen van de voedingsadviezen. Bij alle preventieve 
maatregelen die er worden genomen zijn er van de velen op wie die maatregel 
wordt toegepast uiteindelijk maar enkelen die ook werkelijk ervan zullen profi-
teren. Van alle kinderen die tegen kinderverlamming worden ingeent zouden maar 
enkelen die ziekte gekregen hebben als er niemand werd ingeent. Maar wel is het 
zo, dat 3-maal een prik volledige bescherming tegen de ziekte biedt. In het ge-
val van voeding en hart- en vaatziekten ligt de kosten-baten balans veel 
ongunstiger. Men moet er veel meer voor doen (en laten) en de geboden bescher-
ming blijft desondanks onvolledig. Vragen die meespelen zijn ook b.v.: wat zijn 
de kosten van voedingsveranderingen in termen van persoonlijk leefplezier, 
sociale kontakten e.d. en wat zijn de baten met betrekking tot het voorkomen 
van hart- en vaatziekten? Ook moet rekening gehouden worden met mogelijk nadelige 
gevolgen van het niet opvolgen van voedingsadviezen: meer hartoperaties, meer 
medicijngebruik, invaliditeit etc. Deze vragen gelden niet alleen op individueel 
niveau maar ook op bevolkingsniveau. 
In het nu volgende wordt op de 'kosten-baten' balans wat meer ingegaan. 
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Omdat individuen onderling sterk kunnen verschillen kan een dergelijke afweging 
hier alleen gemaakt worden voor groepen mensen. 
De kosten: welke voedingsveranderingen zijn nodig om een daling van het chole-
sterolgehalte in het bloed te bereiken? 
Doordat er veel onderzoek naar is gedaan kan het effekt van veranderingen 
in de voeding op het cholesterolgehalte in het bloed redelijk worden geschat. 
Daarbij moet wel bedacht worden dat de daling van het cholesterolgehalte in het 
bloed groter is naarmate iemands uitgangsniveau van cholesterol in het bloed 
hoger is en kleiner naarmate dat uitgangsniveau lager is. Zoals al eerder ge-
zegd gel den dergelijke schattingen gemiddeld voor groepen mensen; individuen 
kunnen onderling sterk verschillen in hun reaktie op veranderingen in de voe-
ding. 
De invloed van vet en cholesterol 
Naar de invloed van vet op het totale cholesterolgehalte in het bloed is 
veel onderzoek gedaan. 
Gemiddeld betrekt een Nederlander 40% van de dagelijkse energieopname uit vet. 
Ruim 1/6 hiervan valt in de kategorie meervoudig onverzadigd vet. 
De Nederlandse voedingsraad beveelt aan de totale vetconsumptie te beperken tot 
ongeveer 1/3 van de totale energiehoeveelheid die we per dag opnemen. Daarbij 
zouden verzadigd, enkelvoudig onverzadigd en meervoudig onverzadigd vet elk 1/3 
deel van het geconsumeerde vet moeten uitmaken (elk dus 11% van de dagelijkse 
energieopname). Wanneer een groep mensen overeenkomstig dit advies het energie-
percentage vet in de voeding verlaagt van 40 naar 33% van de dagelijkse energie-
opname heeft dit een gemiddelde daling van het cholesterolgehalte in het bloed 
met ca. 0,25 mmol per liter bloed tot gevolg. Verhoging van het gehalte meer-
voudig onverzadigd vet van 6 naar 11% van de dagelijkse energieopname betekent 
een daling met nog eens 0,15 mmol/1 bloed. Totaal dus 0,4 mmol/1 bloed. Als we 
bedenken dat het cholesterolgehalte voor mensen van 30-40 jaar gemiddeld 5,8 
mmol/1 bloed is betekent dit een daling van 7%. 
Onderzoek van een alternatief 
Het onderzoek dat in dit proefschrift beschreven is, ging om 
de vraag of het hierboven beschreven effekt ook bereikt kan 
worden door alleen maar heel weinig vet te eten (20% van de da-
gelijkse energieopname) en niet de consumptie van meervoudig 
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onverzadigd vet op te voeren, maar wel die van zetmeel. 
Er werden twee proeven uitgevoerd. De eerste proef, met 64 
proefpersonen, duurde 8 weken. De deelnemers werden ingedeeld in 
4 groepen die elke een andere voeding kregen. De voedingen ver-
schilden alleen in de soort vet of in de hoeveelheid vet en zet-
meel. De tweede proef, met 40 deelnemers, duurde 16 weken. In 
die proef werden slechts twee voedingen vergeleken: de aanbevolen 
voeding van de Voedingsraad en de laag-vet voeding. Tijdens de 
proefperiode aten de deelnemers de warme maaltijd op de afdeling 
Voeding van de Landbouwhogeschool en kregen ze een voedselpakket 
mee voor de rest van de dag. Op die manier kon de samenstelling 
van de voeding goed onder controle gehouden worden. Tijdens de 
proef werd op verschillende tijdstippen een klein beetje bloed 
afgenomen voor laboratoriumbepalingen; ook urine en ontlasting 
werden op bepaalde tijdstippen verzameld. 
Het bleek dat de aanbevolen voeding en de laag-vet voeding 
allebei het totale cholesterolgehalte in het bloed verlaagden 
als we vergelijken met de voeding zoals die in welvarende landen 
gebruikelijk is. Maar de laag-vet voeding had als nadeel dat ze 
ook het HDL-cholesterol verlaagde en de hoeveelheid triglyceriden 
(neutraal vet) in het bloed verhoogde en dat deed de aanbevolen 
voeding niet. Enige voorzichtigheid lijkt dus geboden. 
Ook het eten van cholesterolrijke produkten (vooral eieren, lever; maar ook 
vlees, kaas, roomboter en voile melkprodukten) is van belang. Dit is echter 
alleen belangrijk beneden een bepaalde hoeveelheid gegeten cholesterol. 
Veranderingen in de hoeveelheid gegeten cholesterol boven een niveau van 500 mg 
per dag hebben zeer waarschijnlijk nauwelijks effekt op het cholesterolgehalte 
in het bloed. Met andere woorden het maakt waarschijnlijk niet uit, of je nu 
15 of 20 eieren per week eet, maat wel of je van 10 naar 5 eieren gaat. 
Een verlaging van de hoeveelheid cholesterol in de voeding van 450 naar 250 mg 
per dag zal, als we zeer voorzichtig schatten, een daling van ca. 0,10 mmol/1 
bloed teweeg brengen. 
Veranderingen in de soort en hoeveelheid gegeten vet en in de hoeveelheid 
cholesterol kunnen samen zorgen voor een daling in het cholesterolgehalte in 
het bloed van 0,5 mmol/1 bloed. In de praktijk betekent dit: minder vlees eten 
en bij voorkeur mager vlees met magere jus, groentes afgemaakt zonder margarine 
of boter, halfvolle en magere melkprodukten, dieetmargarine i.p.v. 'gewone' 
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margarine en minder eieren. En meer aardappelen, groente, brood etc. 
De invloed van andere voedingsmiddelen op het cholesterolgehalte in net bloed 
Ook van andere voedingsmiddelen dan vet en cholesterol kan een cholesterol-
verlagende werking uitgaan. Door veel fruit en vezelrijke groenten (wel 3 a 4 
ons per dag) te eten kan het cholesterol in het bloed ook nog wat dalen. 
(Vezelrijke groenten zijn groenten rijk aan onverteerbare bestanddelen, zoals 
spinazie, andijvie, bieten). Ook peulvruchten, knoflook en ui zouden een 
cholesterolverlagende werking kunnen hebben. Omdat daar vrij weinig onderzoek 
naar is gedaan kunnen we slechts gokken hoe groot het effekt daarvan is. Door 
het eten van heel veel groenten en fruit, plus gemiddeld ca. 35 g (ongeweekt 
gewicht) peulvruchten per dag plus regelmatig gebruik van knoflook en ui zou 
het cholesterolgehalte met nog eens 0,25 mmol/1 bloed kunnen dalen. 
De totale daling van het cholesterolgehalte in het bloed die met de voeding be-
reikt zou kunnen worden bedraagt dus gemiddeld 0,75 mmol/1 bloed. Dit zou ge-
middeld gelden voor een groep mensen met een gehalte cholesterol in het bloed 
van 5,7 mmol/1. Voor mensen met een cholesterolgehalte van 4 mmol/1 zou deze 
daling ca. 0,35 mmol/1 bloed bedragen en voor mensen met een cholesterolgehalte 
van 8 mmol/1 bloed zou deze daling ca. 1,35 mmol/1 bloed bedragen. 
Het gezamenlijke effekt van al deze voedingsveranderingen tegelijk is ook wel 
eens in een voedingsproef aangetoond en waarschijnlijk zijn dergelijke 
voedingsveranderingen in de praktijk haalbaar. 
De baten: Wat levert verandering van voedselkeuze op wat betreft de kans op een 
hartinfarkt? 
De grote vraag is nu natuurlijk wat alle zorg, die men eventueel op de 
boven beschreven wijze aan de voeding besteedt, oplevert. Met behulp van gege-
vens van een groot bevolkingsonderzoek in het Amerikaanse stadje Framingham is 
geschat hoe groot het effekt van verlaging van het cholesterolgehalte in het 
bloed op het aantal hartinfarkten zou kunnen zijn. Dit voorbeeld dient om een 
indruk te geven van de orde van grootte van het effekt. 
Uit deze berekeningen bleek, dat, als 100 mannen (niet-rokers, met normale 
bloeddruk en geen hartafwijkingen) beginnend op 35-jarige leeftijd, hun chole-
sterolgehalte verlagen van 8 naar 6,7 mmol/1 bloed, 6 van hen hiermee een 
hartinfarkt in de komende 20 jaar voorkomen, 8 zouden zelfs ondanks alles toch 
een hartinfarkt krijgen voor hun 55e jaar en de overige 86 zouden er geen voor-
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deel uit halen. Het risiko daalt dus van 14% naar 8%; een vermindering met 
bijna de helft. Het mogelijke voordeel is kleiner voor vrouwen en voor degenen 
die op latere \eeftijd beginnen, maar groter als het cholesterolgehalte nog 
verder verlaagd wordt en ook groter als er tegelijkertijd ook andere risiko-
faktoren aanwezig zijn. Bijvoorbeeld: als 100 mannen, die sigaretten roken en 
matig verhoogde bloeddruk hebben en een kleine hartafwijking, hun cholesterol-
gehalte in het bloed verlagen van 8 naar 5,4 mmol/1 bloed, zou hun risiko voor 
een hartinfarkt voor het 55e jaar afnemen van 57 naar 29%. 
Konklusie 
Op grond van bovenstaande overwegingen zou men een cholesterolverlagende 
voeding kunnen beschouwen als een soort verzekeringspremie, waarbij de risiko-
dekking voor verschillende situaties verschilt, maar nooit 100% is. 
Op bevolkingsniveau zou verandering van de voeding zeer waarschijnlijk leiden 
tot een daling van het gemiddelde cholesterolgehalte in het bloed en tot daling 
van de sterfte. Per individu kan geen voorspelling qedaan worden of 
voedingsveranderingen een hartinfarkt zullen voorkomen. Dat komt enerzijds 
doordat er grote onderlinge verschillen tussen mensen zijn in de mate waarin hun 
cholesterolgehalte reageert op veranderingen in de voeding. Anderzijds blijft er 
om onbekende redenen altijd een kans bestaan dat iemand ondanks verlaging van 
het cholesterolgehalte in het bloed toch een hartinfarkt krijgt, zoals we in 
bovenstaande voorbeelden hebben willen laten zien. 
Bij het beoordelen van de wenselijkheid van voedingsveranderingen zijn dus de 
'kosten' (in termen van voedingsveranderingen) bekend, terwijl de 'baten' (in 
termen van de kans op hart- en vaatziekten) per individu onvoorspelbaar zijn. 
Dit hoofdstuk is voor het grootste deel gewijd aan voeding en hart- en vaat-
ziekten. Zoals in het begin al is gezegd kunnen ook vermindering van sigaretten-
gebruik en verlaging van de bloeddruk bijdragen aan het verminderen van de kans 
op een hartinfarkt. Deze faktoren zouden in de voorlichting dan ook minstens 
evenveel nadruk moeten krijgen als de faktor voeding. Voeding zelf speelt boven-
dien een rol bij veel meer ziekteprocessen. Denk alleen maar aan alkohol en 
leverziekten, suikers en tandbederf, zout en hoge bloeddruk. Voeding dient niet 
beschouwd te worden als specifiek middel ter voorkoming van ziekten of zelfs 
als medicijn. Voeding heeft zijn plaats in een geheel van aktiviteiten en 
gedragingen onder het hoofd gezondheidsbescherming en -bevordering. Niet meer, 
maar ook niet minder. 
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